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 Atrial fibrillation (AF) is a widely prevalent arrhythmia which affects 
approximately 4.5 million people in Europe and the US, reducing quality of life 
and increasing risk of stroke and death. Considerable research effort is currently 
directed to this arrhythmia because the mechanisms causing its initiation, 
maintenance, and termination are not well understood. This study addresses, at 
a tissue level, the basic descriptors of atrial fibrillation, known causes, and a 
model to utilize in analyzing heart wave characteristics such as propagation 
velocity, action potential duration and others for potential use in developing early 
detection methods of AF. The tissue model methodology, based on epicardial 
tissue and kinetics from a cellular model, utilized the MATLAB PDEPE solver on 
a 1 x .0011cm tissue strip, enabling research into complex action potential (AP) 
and AP propagation characteristics. The model represented left atrial tissue sinus 
rhythm (SR) and AF states as defined in Grandi et al.23 with comprehensive state 
variables and ionic currents as well as complete cellular physiology including 
excitation contraction coupling with sarcoplasmic reticulum Ca2+ ATPase, 
calcium-induced calcium release, Ca2+ and Na+ buffer fluxes, subcellular sections 
and diffusion factors. Based on following the nonlinear response cascade of the 
potassium channels during the progression to AF, the tissue model study 
provides insight into wave propagation velocity, atrial AP amplitude, action 
potential duration, non-refractory periods, in addition to other wave 
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characteristics through rates of change, greater than 50%. Regardless of the 
many known forms of AF, which often involve polygenetic and other cardiac 
pathologies, this human atrial tissue model study, with its completeness of 
cardiac cell and tissue representation, provides a basis for further analysis 
research and modeling because the cardiac structures used can be modified to 
represent or independently model other potential cardiac pathologies that 
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Chapter 1. Introduction 
1.1 Atrial Fibrillation Background 
Various forms of AF currently affect 1% of the population, 8% of those over 
age 8046, and are expected to impact more than 16 million Americans by 205051. 
Due to the wide heterogeneity of its underlying pathophysiology, its different 
symptomatic impact on each patient, and the possibility of different therapeutic 
options, AF represents a great challenge for clinicians17. Some genetic forms of 
AF, such as those associated with the 10q22-q24 chromosomes, have no 
associated electrocardiographic abnormalities33,35. In the electrocardiogram, AF 
is characterized by rapid atrial activity that is irregular in timing and morphology 
(Fig. 1). Discrete P waves are absent and replaced by an oscillating baseline that 
consists of low-amplitude fibrillatory f-waves17. Human and experimental studies 
have shown that effective shortening of the AP refractory period, the period when 
the cardiac tissue cannot be depolarized, is an essential feature of atrial 
fibrillation17. 
 
Fig. 1 ECG of atrial fibrillation (top) and 
normal sinus rhythm (bottom). The purple 




At the atrial level, characterization of fibrillatory f-waves during AF with 
spectral analysis of P wave signal averaging, using sinus rhythm as a baseline, 
has been successfully applied to monitor and predict outcome of antiarrhythmic 
drug therapy and cardioversion17. Electrocardiographic imaging is also being 
used to discern atrial heart wave behavior32. 
The classification scheme used for AF is 1) paroxysmal AF, i.e. AF with 
spontaneous interruption generally within 7 days but mostly in 24-48 hours; 2) 
persistent AF, i.e. AF that, independently of its duration, does not interrupt 
spontaneously, but with therapeutical intervention (pharmacological or electrical); 
and 3) permanent or chronic AF, i.e. AF in which interruption attempts have not 
been made or, if made they were not successful, i.e. failed restoration of sinus 
rhythm17. AF is also an electrical disruption of cardiac excitation and propagation 
whose initiation depends on the presence of triggers46 and maintenance requires 
appropriate arrhythmogenic substrate36. This study is an effort to address 
prediction of class 1 and 2 AF based on known electro-chemical cardiac 
properties. 
AF has been characterized as having focal triggers in the pulmonary vein 
interface within the heart and left atrium36. The triggers manifest themselves as 
early after-depolarization (EAD) and delayed after-depolarization (DAD) with 
associated electrical waves. Maintenance of AF is through wave breaks and 
associated points of singularity (PS) in heterogeneous tissue.  The points of 
singularity (PS) define anchors for wave breaks, referred to as wavelets, in 
heterogeneous repolarizing cardiac tissue. These wavelets create re-entrant 
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points or points of excitation outside the normal left atrial sinus rhythm. As AF 
progresses from paroxysmal to persistent the triggers move from the left to the 
right atria believed to be caused by the down regulation of transient outward K+ 
current (Ito)52, inward calcium current (ICa) and inward sodium current (INa) ion 
channels in the right and left atrial myocytes36. This study addresses the left atrial 
tissue but the structure can be applied to the right atrial and other cardiac 
regions.     
Cellular and molecular behavior involved in AF is influenced by signaling 
factors, ionic concentrations and stimulus currents36. Cardiac ion channels, 
involved in AF, are generally classified as passive channels, metabolic pumps 
utilizing adenosine triphosphate (ATP), or exchangers leveraging chemical 
gradients. Selectivity is controlled through protein structure. Activity control is via 
voltage-activated gating states (open, closed, inactive) through Na+, Ca2+, some 
K+ channels and, ligand-gated through acetylcholine (ACh) and ATP among 
others. Mechanical stretch is also a determining ionic factor5,16,36. This study 
focuses on these ionic flows. 
Additionally, AF is increasingly recognized as having genetic 
underpinnings25,15,33 (Appendix B). AF is characterized by association with other 
cardiac disease states, which applies to 70-85% of AF cases, or without a known 
association and etiology, which is 15-30% of AF cases, also known as lone AF33. 
Lone AF causation is suspected of being genetically determined. Therefore 
identifying patients with genetic defects predisposing to AF provides a unique 
opportunity to potentially address lone AF or AF in and of itself33.   
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Lone AF has been isolated in monogenic and polymorphic forms, with 
monogenic forms related to genes KCNQ1, KCNE2, KCNJ2, KCNA5, SCN5A, 
and CJA5 among others. Atrial flutter, paroxysmal AF, and chronic lone AF have 
been associated with these genes with most associations being paroxysmal 
AF33. In some cases KCNQ1 is linked to familial AF by increasing the slow 
activating potassium current (IKs)33,35 expression and currents. HERG-37 genetic 
defects affect IKs and repolarization in the cardiac tissue and impair the heart’s 
ability to respond to changes in rate14,33. Short QT syndrome genetic defects in 
inward rectifier K+ current (IKi) channels are believed to cause familial AF14,33. 
ATP reductions and Na+/K+ ATPase impacts of late sodium inward current (INaL) 
create appearances of K+ related fibrillations10,33,63. 
ATP driven potassium channel (IKATP) gene Kir6.2 K23 Allele is a risk factor 
in 50% of the population, but not a predictor, for transition from hypertension 
stress load to sub clinical maladaptive cardiac remodeling15,33. Vulnerability to 
arrhythmia is created by the inability of IKATP channels to safe guard against 
adrenergic stress induced ectopy15,33 and in general IKATP challenges are 
believed to cause lone AF15,33. Additionally magnesium (Mg2+) acts to reduce the 
inhibitory impact of ATP on K+ expression that enables IKATP to have a positive 





There are many identified genetic drivers of inherited AF as well as lone AF – 
which in some cases are one and the same. The primary impacts (Fig. 2 and 
Appendix B) of the genetic defect for AF are gain of function in the Iks current via 
reduced APD and refractory period, the potassium fast transient outward current 
(Itof) via reduced AP duration (APD) and refractory period, and loss of function in 
the ultra-rapid delayed rectifier potassium current (Ikur) via lengthened APD and 
early after depolarization33 and rapidly activating potassium current (Ikr) through 
decreased gap junction density33. Other research38 suggests loss of function in 
calcium currents (ICaL), Ito, IKur and sarcoplasmic reticulum Ca2+ ATPase 
(SERCA), along with gain of function in IKi, IKs, and Na+ Ca2+ exchanger current 
(Incx) based on an assumed mixed etiology polygenic AF as reported by Grandi et 
 
Fig. 2 Cardiac action potential (red tracing) and atrial ionic impacts in AF33 in 
the action potential (see Appendix C for definitions). 
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al.23 in their modeling. The tissue model utilized in this study is able to represent 
most if not all these conditions. 
General consensus is that AF begets AF62 – unresolved lone paroxysmal AF 
leads to more severe and chronic fibrillation and heart disease42,43,33,35 through 
various forms of cardiac remodeling and ion channel protein transcription 
alterations.   
The elements used in atrial tissue models to analyze AF include the ionic 
channels of the left atrial chamber14,17,29,46,47, the ionic densities in epicardial39,86 
heart tissue, ion channel specificity and expression35, anisotropic propagation, 
propagation safety factor, cellular temperature, tissue heterogeneity, ion 
chemical balance and polarization, and mutual entrainment within the sinoatrial 
node (SA), and atrioventricular node (AV) and bundle of His (NH) cardiac 
structures16,36.   
In summary, AF is a significant pathology and there is growing evidence that, 
at least for some portion of AF, AF has unique genetic causes. In addition to 
those unique genetic causes, AF is believed to be associated with degenerative 
heart remodeling that leads to further cardiac pathologies including more severe 
forms of AF. 
There is significant motivation for research into early detection and 
assessment of this condition beyond genetic testing that could alert individuals to 
risk factors. The tissue model developed in this research is intended to provide 




1.2 Tissue Model Study Objective 
The underlying changes in atrial AP can lead to AF beginning much earlier 
and at levels below that which cannot be detected by either conventional 
methods such as electrocardiogram (ECG), or human discomfort such as 
“fluttering in the chest”. Scientific research has determined that AF is potentially 
initiated in its inception through genetic alterations at the cellular level through 
established and documented ion channel structures. Ionic cellular models23,26,28 
have been developed that represent mathematically, the ionic channel conditions 
that are believed needed for  establishment of chronic AF (cAF). ECGs and 
patient self-diagnostics can detect AF in all forms after AF remodeling has 
developed to a significant level. The hypothesis is that an atrial tissue model can 
be developed to model heart wave in sinus rhythm and atrial fibrillation 
conditions, as defined by Grandi et al.23 based on wave form, amplitude, and 
frequency. Detection/prediction, along with genetic testing, can be made before 
ECGs and patient self-diagnostics, with the critical benefit that the degenerative 
cardiac remodeling can potentially be arrested early, leading to the delay and 
prevention of the development of AF. The objective is to develop an ionic and 
physiologically accurate model that will provide heart wave analysis of  the 
underlying changes induced by AF remodeling in Ca2+, K+, and Na+ parameters 
as defined by Grandi et al.23. With appropriate and developing technology, this 
model can assist in early detection/prediction based on any of several signal 
analysis algorithms such as rhythm, regularity, synchronization, or morphology 
based analysis, of the simulated atrial AP and AP propagation wave forms. 
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Chapter 2 Methods 
2.1 Model Physiology 
The tissue model developed in this study is based on concepts from a 
cellular human atrial model, developed by Grandi et al.23 (Fig. 3A) validated for 
sinus rhythm and chronic AF (Table 1 and Appendix A). The model is one of the 
most advanced models available, in terms of detailed ionic channel kinetics and 
excitation contraction coupling, found in the literature research. The heart wave 
propagation was modeled based on the concepts of the Livshitz et al.12 guinea 
pig myocyte model (Fig. 3B). The Livshitz model concepts were modified for 
alignment with the Grandi concepts, and both concepts were modified to 
accommodate atrial tissue propagation and key ionic variables (Fig. 10). 
The model developed has the following elements considered key based on 
literature12,23,26,28,34 review: 1) accurately reflects Ca2+ dependent Ca2+ release in 
human heart representation80; 2) uses realistic parameters, particularly those that 
concern Ca2+ transport from the cytosol; 3) comes to a steady state, which is key 
in measuring parameter impacts in relevant physiological ranges ; 4) simulates 
basic excitation-contraction coupling phenomena; 5) includes a sub-sarcolemma 
       
A - Atrial Cell Model28 Modified  B - Atrial Tissue Model12  
Fig. 3 Pathological atrial cell (A) and tissue (B) concepts used in study. Refer 




compartment in addition to the two commonly formulated compartments 
(junctional and bulk) because ion channels in the membrane sense ion 
concentrations that differ from the bulk; 6) uses realistic cytosolic buffering 
parameters; 7) includes sarcoplasmic reticulum (SR) Ca2+ pump; -a scheme for 
Na+-Ca2+ exchange transport that is [Na+]I dependent and allosterically regulated 
by [Ca2+]I; 8) uses a practical model of SR Ca2+ release including both 
inactivation/adaption; 9) includes SR Ca2+ load dependence, via a Markov model 
recognition of Iks ability to form an available reserve when Ikr, the rapid delay 
rectifier is reduced through disease or drug; 10) includes Mg2+ handling which 
impacts IKATP; and 11) has extensive K+ channel representation. The requirement 
for these elements includes the remodeling of K+ channels in SR62, the 
relationship to and cellular regulatory effects of Ca2+ , [Ca]i , ryanodine receptor 
(RyR), SERC, SR and Incx , and the excitation contraction (EC) phenomenon 
associated with them57,59,60,61,69. 
Several other concepts were considered or reviewed for input to the human 
atrial tissue model. These included the Lou-Rudy dynamic (LRd)11,64,65 for initial 
concepts and Markov element construction, the bidomain13 model for 3D 
representation, the simple, 3D right atrium model22 that computes at near 
physiological speeds, meshing 3D models48 and for a more complex cardiac 






2.2 Critical Tissue Model Ionic Parameters 
The critical ionic parameters to be modified are based from literature and 
complement the existing modeling to date (Table 1). The nature of AF suggests a 
methodical approach to variation of parameters Iks, Itof, Ikur, and 
Ikr5,6,9,12,14,16,33,39,51, would be altered through the Nernst equilibrium, conductance 
values, pump rates, concentrations, and/or buffers while Ikr would be altered 
through gap  junction densities. For AF detection purposes in this study, the 
Grandi et al.23 parameters are used to define AF. The ionic kinetics of the model, 
along with accompanying changes in association/disassociation and equilibrium 
constants, are structured for modification in the manner represented in literature. 
Other key19,24,49,51,67,70,71 ionic factors and their cellular AP impact, such as 
calcium concentration [Ca2+]i, calcium current ICa, calcium markov gates, and 
acetylcholine potassium IKACh are included to provide complete atrial 
representation and are analyzed as appropriate for this study (Fig. 2).  
Table 1. Model Atrial Fibrillation Factors 
 
Ionic Currents Ca and Na Handling
INa -10% peak density ICaL
Current density is reduced by 50% in 
AF. No Changes in voltage dependence 
of activation and inactivation
INaL Added Late Component INcx Upregulated in AF (+40%)
IKs Increased 2-fold SERCA Reduced maximal pump rate
IKr Unchanged RyR
Increased sensitivey for luminal Ca2+ (2 
fold)
IKur -45% in the LA SR Ca
2+ leak Increased by 25%
IKi Upregulated +100% Tnl Unchanged
Ito Itof  -45% INak Unchanged
Model Atrial Fibrillation Factors 23 
Adjustments to SR for AF
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The models assume cellular and tissue dimensions from the literature12,23 
which are single strand tissue of approximately 1 cm in length and 0.0011 cm 
diameter. Initial values for model parameters utilized were those published in 
literature or made available with the models.  
The tissue model is structured in a manner that allows for investigation of 
numerous combinations of ionic states and flows as well as cellular and tissue 




Grandi et al. 23 
t0 alternan
Grandi et al. 23 
Cell Model less 
ODE15S Solver
Grandi et al. 23  
Cell Model 
Constants




























 2.3 Model Input Variables 
The input variables were structured to represent the previously mentioned 
elements of ionic channel state, tissue heterogeneity, and anisotropic 
propagation etc. (Table 2). For cell length and radius, model mathematical 
limitations naturally set range limits (points of singularity, imaginary number 
outputs etc.).  
Model states to simulate sinus rhythm (SR) and atrial fibrillation (AF) were 
taken from Grandi et al.23 and served as the analysis baseline for model outputs 
used for AF detection. A unique and key aspect of this human atrial tissue strand 
study was the method of model construction that allowed for progression of the 
model from SR state to AF state through incremental changes in application of 
the Grandi et al.23 AF factors. An arbitrary scale, as shown in Table 3 was 
Table 2. Input Variables 
 
Variable Base State UOM
Cell Length SR 75 90 100 150 200 µm
Cell Radius SR 8.200 8.713 10.250 12.300 13.325 µm
Diffusion Coefficient (E-4) SR 35 70 120 175 275
Graduated AF Protocol SR 0 0.25 0.5 0.75 1
Graduated AF Early SR 0 0.0625 0.125 0.1875 0.25
Split Tissue Diff Coef (E-4) SR - AF 35 SR 70 - 35 35 - 07 70 - 07 -
AVE0118 AF 0 1 10 30 100 µM
AVE0118 SR 0 1 10 30 100 µM
Acetylcholine SR 0 0.001 0.010 0.100 1 µM
Junctional Volume SR 1.7790E-14 4.4476E-14 8.8952E-14 1.3343E-13 1.7790E-13 L
Intracellaur Diffusion SR
1.6400E-07 8.2000E-07 1.6400E-06 8.2000E-06 1.6400E-05 cm^2/sec
1.2200E-07 6.1000E-07 1.2200E-06 6.1000E-06 1.2200E-05 cm^2/sec
1.0900E-06 5.4500E-06 1.0900E-05 5.4500E-05 1.0900E-04 cm^2/sec
1.7900E-06 8.9500E-06 1.7900E-05 8.9500E-05 1.7900E-04 cm^2/sec
0.1X 0.5X Base 5X 10X
SR state of variable
Variable values
                  Diffusion Coef Ca+ Junctional to Sarcolemma
                  Diffusion Coef Na Junctional to Sarcolemma
                  Diffusion Coef Ca+ Sarcolemma to Cyto
                  Diffusion Coef Na Sarcolemma to Cyto
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selected that subdivided in a linear manner the progression of the AF factor 
application into 5 steps from 0 = SR state to 1 = AF state. The model displays a 
nonlinear response in the output variables that was consistent across outputs 
and in key output variables provided early AF detection opportunities because of 
the fast response to the linear changes in input. The nonlinear response of ionic 
channels to regulation inputs, remodeling and other challenges is documented in 
AF literature51.  
Model states 0-SR through 1-AF were varied sequentially as a unique 
modeling event to evaluate the potential AF detection at each AF level – 0, .25, 
.50, .75, and 1.This progression in 5 steps as identified in the table is referred to 
as “graduated AF” in the remainder of this report. The “graduated AF” approach 
is utilized as the baseline AF development progression against which all other 
study variations are compared. Because of the 5 step progression from SR to AF 
all variable inputs are introduced to the tissue model in 5 increments to allow for 
comparison of output characteristics that follow in the results section. Additionally 
other non-ionic variable changes were usually compared to an SR baseline. 









25% AF 0.25 .25AF
50% AF 0.50 .50AF
75% AF 0.75 .75AF
AF 1.00 AF
Code Fribillation Factor Table
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2.4 Model Output Variables 
Table 4 shows the atrial tissue model wave characterization output factors. 
The model output variables were drawn from literature and used to assess AF. 
All output variables were analyzed directly in MATLAB. Output across the 
variables proved to be consistent within a sub project group. Some of the output 
phenomenon is due to the dependent nature of the variables created by the 
model.  Therefore because the model was consistent, beyond the model 
validation discussion, not all variables are included in the discussion. Because 
the model used a fixed basic cell cycle time, pacing at various Hz is not done. 
Future versions of the model may be designed with this feature. 
From Table 4, all output definitions are applied to all tissue elements and 
reported for the 4th basic cycle length (BCL) or pulse. Pulse 4 was chosen in 
order to avoid edge effects in both time and distance, pulse 1 was avoided due to 
stimulus artifacts. The mean of an output variable value was calculated within 
each BCL and then averaged across all cells (distance x). The non-refractory 
tissue is defined as that tissue where the membrane potential is less than 10% of 
16  
 
the maximum action potential voltage. The value of 10% was chosen consistent 
with methodologies within or implied in the literature reviewed2,11,18,20,33,40,62,73. 
APD is defined as the duration that the AP is greater than 10% of maximum 
AP voltage. 
MaxTMP is the mean time of the maximum membrane potential value.   
MinTMP is the mean time of the minimum membrane potential value and 
provides the timing of the AP upstroke.   




% tissue in non-refractory period for each pulse and 
distance x %
APD Action potential duration for each pulse and distance x mS
MaxTMP
Timing of maximum membrane potential for each pulse 
and x mS
MinTMP
Timing of minimum membrane potential for each pulse 
and distance x mS
MaxDeltaTMP
Timing of maximum membrane potential change for each 
pulse and distance x mS
RangeTMP
Range of maximum to minimum membrane potential in 
mS for each pulse and distance x mV
MaximumAP
maximum membrane potential for each pulse and 
distance x mV
MinimumAP
minimum membrane potential for each pulse and 
distance x mV
ChangeTMP
maximum membrane potential change for each pulse 
and distance x - calculated to represent action potential 
up stroke velocity mV/ms
Prop Velocity Propagation velocity across entire tissue distance µm/ms
Visual Visual inspection of membrane potential surface plot
Atrial Tissue Wave Charaterization Output Factors
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MaxDeltaTMP is the mean time of the maximum membrane potential change 
and provides a measure of changes in propagation variability along the tissue 
strand. 
RangeTMP is the mean of the absolute difference between the maximum 
and minimum of the AP and represents the mean AP peak height.  
MaximumAP is the mean maximum membrane potential value.  
MinimumAP is the mean minimum membrane potential value, within a BCL, 
for each t series across all x and provides the value of the low side of the AP. 
ChangeTMP is the mean maximum membrane potential change and 
provides the maximum AP upstroke velocity in mV/ms. 
Prop Velocity is the change in time, within a BCL, of the maximum AP 
upstroke value from x = 1 to x = 100 (or cell 1 to cell 100) for pulse 4 and referred 
to as propagation velocity. Propagation velocity is not a mean value. 
2.5 Model Mathematics  
The mathematical basis for the propagation model comes from Livshitz et 
al.12 and was designed based on utilization of the MATLAB PDEPE solver. 
MATLAB PDEPE program equation in generic form is 






(𝑥𝑚𝑓 (𝑥, 𝑡, 𝑣,
𝜕𝑣
𝜕𝑥
)) + 𝑠 (𝑥, 𝑡, 𝑣
𝜕𝑣
𝜕𝑥
).                        (1) 
Where x is distance, t is time, v is voltage, c is a function of x, t and v, m is the 
problem type whose value is 0 for slab in this model, and s is a function of x, t 
and v which is the membrane potential equation in this model. Axial current flow 
which correlates to the diffusion coefficient below is 
𝑓 (𝑥, 𝑡, 𝑣,
𝜕𝑣
𝜕𝑥
) =  −𝜆2
𝜕𝑉(𝑥,𝑡)
𝜕𝑥
                                            (2) 
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where 𝜆 is resistance. Cell model in generic form modified with the kinetics from 
Grandi et al.23 model is 
𝑠 (𝑥, 𝑡, 𝑣
𝜕𝑣
𝜕𝑥
) = 𝐺 ∑ 𝑖𝑜𝑛𝑖𝑐 𝑐𝑢𝑟𝑟𝑒𝑛𝑡𝑠.                                          (3) 
where 𝑠 is the membrane potential function and 𝐺 is the membrane conductance. 
Initial conditions taken from Grandi et al.23 are 
𝑉(𝑡𝑜, 𝑥) = 𝑡𝑜(𝑥).                                                   (4) 
where V is the definition of membrane voltage. Boundary conditions derived from 
Livshitz et al.12 are 
𝑝(𝑡, 𝑥, 𝑣) + 𝑞(𝑡, 𝑥)𝑓 (𝑡, 𝑥, 𝑣,
𝜕𝑣
𝜕𝑥
) = 0.                                (5) 
where p and q are functions of t, x, and v that define the boundary values. 







.                                      (6) 
where 𝑖′sim is the stimulus, 𝑖′ion is the transmembrane ionic currents and D is the 
diffusion value. Livshitz et al.12 diffusion factor (D) for axial current (resistance 










)/𝑐m.                                      (7) 
where 𝑟𝑚 is membrane resistance , 𝑟𝑖 is intracellular resistance, 𝑟𝑜is extracellular 
resistance , 𝜎a is the intracellular conductance per unit cable length , 𝜎g is 
extracellular conductance per unit cable length , and 𝑐m is capacitance per unit 
cable length. Livshitz et al.12 gap junction and cell size impacts with a = radius, 𝜎 a 
= intracellular conductance, 𝜎g = extracellular conductance, and 𝜎g calculated are 
𝜎a=σmyo*(𝜋)*a2                                                                         (8) 
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 𝑐m = 𝐶sc ∗ 2(𝜋) ∗ 𝑎.                                                                      (9) 
where σmyo is mycoplasma specific conductivity and 𝐶sc is cell surface 
conductivity. Huxley-Hodgkin5 form of the action potential and ionic currents of 
which a modified version was used by Grandi et al.23 in the model kinetics is 
      appLLKKNaNam IVVgVVgVVg
dt
dV
C  .                                   (10) 
In Fig. 4, for the human atrial tissue model a mesh time Δt and mesh 
distance Δx was determined from literature4,5,12,14,23,26,28 and an initial conditions 
t0 as described later was input to the MATLAB PDEPE partial differential 
equation solver. The PDEPE called the human atrial cell model function and 
solved for dV/dt for the time mesh, then called the diffusion coefficient D function, 
and calculated downstream membrane potential diffusion. The PDEPE then 
incremented the Δx and iteratively solved for dV/dt in the time mesh and diffusion 
factor across each increment of the x. 
The model “pulsed” or extended simulation in time by another basic cycle 
length (BCL) by taking the final time solution for all x from the first solution set, 
and reinserting final time solution values as a new initial condition t0 for the next 
time and distance mesh. The pulse iteration is called by code that encompasses 
the PDEPE solver, and the pulse solution sets are merged to form the continuous 
solution output and membrane potential plots. 
The mathematics that drove the model size were the time (t, 600 ms) which 
equated to the BCL, the total distance (x,100 cells) in tissue length, and the 
number of pulses (N repeats of BCL). The time mesh and distance mesh 
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remained the same throughout the model study iterations unless otherwise 
noted. 
2.6 Model Build Approach 
The approach to building the model architecture, illustrated in Fig. 4, evolved 
from research of existing cellular and tissue model concepts such as the Livshitz 
et al.12and Grandi et al.23 models. The original Livshitz et al.12 model was 
downloaded in MATLAB code from the Rudy Laboratory at Washington 
University, St Louis. The original Grandi et al.23 model was downloaded in 
MATLAB code from the University of California Davis Pharmacology labs 
program. 
The code for this study was derived from significant modifications and 
concept utilization of the Livshitz et al.12, Grandi et al.23,26,28 , and various Rudy 
models14,34,39,64,65,83. In addition, concepts were drawn from models in 
literature1,2,3,4,7,13,15,18,20,27,36 . Code for activating the Markov model was taken 
from literature11, 23, 52. Code for the AVE0118 and acetylcholine challenges was 
based mathematical formulas derived from literature review 23,40,41,78,79,80,81,82,83 
and inserted in the model as appropriate for hypothesis testing. 
The initial conditions t0 for this study were derived from the cell model initial 
conditions contained in the Grandi et al.23 MATLAB download code. Those initial 
conditions t0 were restated into the format utilized by the Livshitz et al.12 model – 
primarily by constructing repetitive t0 data for each Δx increment step of the 
distance mesh representing the tissue strand in this study. The initial conditions 
are scaled to the width x of the tissue as needed. When new variables were 
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introduced to the model differential equation initial values were drawn from 
literature. The methodology offers a convenient method for insertion of human 
physiological data if available as well as provided a clean starting point transition 
from a cell model to a tissue model. 
The Livshitz et al.12 model concepts and template provided critical methods 
for construction of the model execution file, the PDEPE approach, model 
constants integration through the various MATLAB workspaces and the biphasic 
stimulation approach which in total pulse summed to zero but provided for the 
effects of upstream gain and downstream loss of charge through the tissue. The 
Livshitz et al.12 model also provided the boundary conditions, which were 
introduced as 0 and the initial diffusion factor. The Grandi et al.23 model provided 
the human atrial cell kinetics concepts, model constants and as indicated, the 
initial conditions. The Iks and Ca Markov code and the Ca SR release flux 
mechanism code are some of the most critical and complex in the model and 
therefore used as is from Grandi et al.23. The same 5 basic model MATLAB code 
files, the model execution program, the PDEPE program, the human cell kinetics 
program, the model constants file and initial conditions file provided the model 
platform for study iterations and discussions that follow.   
The initial model was constructed in size based on the Livshitz et al.12 model 
– (4 pulses, 400 ms (BCL) and 50 cells). Each cell is .01 cm long and therefore 
the model represents, at the x mesh used, .5 cm of tissue. The model was 
initiated at 400 ms but required reconfiguration to 500 ms BCL with all other 
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Grandi et al.23 model constants, initial conditions and cell kinetics maintained. 
The model runs in this mode in approximately 20 minutes. 
The model was then successfully run as per above, but extended to 8 pulses, 
i.e. extension in time, and at 50 cells wide. The model output stabilized at 8 
pulses with a diffusion coefficient of .0035 (versus the initial Livshitz et al.12 value 
of .0007). The diffusion coefficient value was derived through substitution of 
known human atrial values in the Livshitz et al.12 diffusion coefficient equation 
and confirmed for all x by consistent peak membrane potential across the pulse.  
The model was then expanded to 8 pulses and 100 cells wide to provide both 
time and distance parameters without edge effects. The initial conditions file t0 
again was created from the Grandi, et al.23 model but replicated by an identical 
100 to match the model cellular structure. The BCL was increased to 600 ms to 
account for the forward propagation wave movement across 100 cells in 8 
pulses. This is the model configuration used for discussion outputs in the study. 
The model runs in approximately 3 hours.  
The analytics code was established as arrays of solution data that 
collectively represented the model solution output and membrane potential plot. 
The final state was chosen, to provide significant tissue area in which analysis 
could be completed yet balance the significant amount of data (500 MB) each 
iteration created. A 32 pulse 100 cell 700 BCL model was used for successful 
model validation with a run time in excess of 8 hours. 
2.7 Atrial Fibrillation Detection 
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The intent of this study is to provide a tool for potential early AF detection. 
From the earlier discussions on AF background and literature review, P waves 
from the ECG and other signal methods are often used for arrhythmia detection 
and management including AF17. Potential signal detection/prediction algorithms 
include mean atrial rate, rate and count, ‘X out of Y’, beat –to-beat and combined 
algorithms17. In addition, AP propagation safety factor, curve fitting, specific 
integration and slope analysis have been used in efforts towards AF identification 
and analysis14.    
The intent of the signal analysis is to provide a degree of correlation with 
diagnosis from more conventional ECG. Research on AF has stimulated the 
development of a wide range of signal processing tools to better understand the 
mechanisms of AF initiation, maintenance and termination. For example, the 
wave length concept has been presented as a potential model of AF activation. 
The average size of reentry pathways during AF is dependent of atrial 
wavelength defined by the product of conduction velocity and refractory period, 
i.e. the time that the atrial tissue is not excitable. Longer wavelengths are 
associated with larger and few wave fronts, while short wave lengths result in a 
large number of smaller circuits which may have implications for arrhythmia 
susceptibility and stability17. With the aim of aiding early AF detection and an eye 
towards future provision of physiological meaningful inputs, specifically current or 
flux into a more advanced volume AF models, the input and output variables 
were identified that provided physiologically relevant balance of atrial scenarios 
and wave factors that the model could support.  Additionally with earlier detection 
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of atrial fibrillation f-waves, a feedback scheme for wave correction could be 
developed to provide a further model of initiation, detection, and correction.    
Most standards of change defining AF were developed after AF had been 
diagnosed. The change standard threshold defined by the study output variables 
below are intended for use prior to AF diagnosis. In order to extend a detection 
concept the model was run in SR state, then in AF state as defined by the model 
variable change in Table 2 and Table 3. The variables that were measured, as 
the model outputs, are shown in Table 4. The results were reviewed for 
significance, a percentage change of 25% in propagation velocity was arbitrarily, 
but not unreasonably17,34 assumed detectable by electrocardiographic imaging 
methods. Detection of the change in APD and other model output elements of 
the heart wave model are challenged by current technology. The development of 
advanced electrodes, such as the ablation probes and flexible micro electrodes 
offers encouragement that the detection technology progression will continue. In 
preliminary simulations wave propagation exceeded 50% reduction, approaching 
a 61% reduction for propagation velocity. On the other hand, APD decreased 
12%. Based on the initial propagation findings, the 10 parameters identified in the 
study (Table 4), were determined from literature17,32 to be an acceptable method 
of wave analysis for AF.  
2.8 Modeling Approach 
The study was organized around 9 subprojects as shown in Table 5. Project 
elements were intended to study the ability for AF detection under varying ionic 
and physical property conditions. Subprojects SR and AF Baseline, and Model 
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Validation were used to validate the model. The references shown in the table 
sections drove the ideation but not necessarily the parameter value selection 
which is discussed in the sections that follow. 
The variables that were modified as inputs and values used are shown in 
Table 2. Not all variables show linkage to references. Where, based on the 
uniqueness of the model, and if variable values where not published, the 
variables were varied around the base state SR conditions unless otherwise 
noted in the sections below. There were additional iterations of the modeling that 
providing no further information or guidance to further analysis. Those additional 
iterations are not reported here but include concepts such as stimulus variation.  
Table 5. Tissue Model Study Project Elements. 
Element Baseline Adjustments 




Model Baseline – SR 
and AF12,14,23,26,28 
Sinus Rhythm Graduated AF, 
Reference Table 3 Code 
Fibrillation Factors and, 
Table 2 Model Atrial 
Fibrillation Factors 
Early AF Graduated AF Table 3 Code – 1st Two 
Steps in AF Progression 
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Table 5. Tissue Model Study Project Elements Cont’d. 
Element Baseline Adjustments 
*External Cell 
Geometry12,14,23,26,28 
Graduated AF External Cell Radius 
External Cell Length 
Split Tissue 
Condition45,72  
Graduated AF 1st ½ Tissue SR 
2nd ½ Tissue AF 
*External Diffusion 
Coefficient12,14,23,26,28 
Graduated AF External Cell Model 
Diffusion Factor 
Isolated K+ and Na+, 
Ca2+ Ionic 
Impacts12,14,23,26,28 





Graduated AF Sarcolemma to 
Junctional Space 
Diffusion 
Junctional Volume Ratio 
to Total Cell Volume 
Β Adrenergic 
Challenge23,87 
Graduated AF ISO Factors 
*Results Shown in Appendices 
 
2.9 Baseline Construction 
The process to construct the comparisons to baseline values was: first) set 
the input variable through the constants file and run the model to generate an 
iteration solution set – generally the model state was SR in order to see if the 
input variable change altered the SR state relative to AF, second) through the 
27  
 
analytics program calculate the currents and non-solution variables within each 
BCL of the solution set, third) through additional analytics programs calculate the 
output variables data for each BCL for every t column across all x of the solution 
set, fourth) in the analytics program calculate the value for all BCL for each 
particular output variable in the solution set, and finally, fifth) overlay selected 
output variables against the corresponding baseline data in chart and table form. 
For each scenario (for example external cell geometry) a consolidated data 
set was created as in Appendix F, A Scenario Model Iteration Data Set. From the 
model iteration data set a particular output variable was selected for comparison 
to the baseline data for that output variable as shown in Appendix F, A Scenario 
Variable Comparison to Baseline. Note all scenarios are 5 iterations of the model 
reflecting the SR to AF progression scheme. Beyond baseline some scenarios 
are iterations of the SR to AF progression with a frozen fixed input variable value 
such as potassium values, while others, as illustrated in Appendix F, A Variable 
Scenario Model Iteration Data Set, and A Scenario Output Variable Comparison 
to Baseline, involved the model locked in a fixed state, generally SR, and the 
input variable incremented/decremented with each of the scenarios 5 model 
iterations. An iteration resulted in 5 data arrays of 9600 X 100 X 102 data 
elements in size.   
The outcomes for propagation velocity, shown in Table 6, detailed by the 
input varaible, for the various senerios are shown by iteration of the model. If the 
measureable change in propagation velocity is greater than 25% from the SR 
baseline then the senario is considered successful in potentially predicting an AF 
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outcome. The model baseline for AF development, is defined as the model with 
all variables held constant, except for the Grandi et al.23 changes identified in 
Table 1, which were incremented per the schedule of Table 3. Graphic output of 
the baseline model is shown in each section. The baseline scenerio of the model, 
as defined and shown in row 1, Table 6, was greater than 25% and therefore the 
model is considered successful as a potential predictor of AF as defined by the 
changes defined by Grandi et al.23. 
2.10 Computation Equipment 
The model was designed and run on standalone PCs utilizing both Microsoft 
Windows versions 7 and 8.1 with MATLAB versions R2011b, R2013b and 
R2014a. All results presented in this report are from the MATLAB R2014a 




Chapter 3 Results 
3.1 Model Validation 
To provide a logical validation method, considering the tissue model was 
derived from several model concepts, 10 elements were addressed – APD, mean 
maximum membrane potential change, calcium concentration, Ca2+ SR flux 
release, calcium currents, acetylcholine challenge, AVE0118 challenge, a steady 
state challenge as per Livshitz et al.12, and later in discussion sections an IKs 
Markov model and the elements of the potassium current. Calcium ionic currents 
and concentrations, key to excitation contraction coupling, are included here for 
proper diligence to that element of the physiology. Because of the model 
differences with those in literature, directional trends, such increasing or 
decreasing potential and or concentration levels, are sometimes discussed. 
In Fig. 5A, APD decreased as predicted23 from 515 ms in SR to slightly less 
than 455 ms in full AF conditions. This is consistent with the cellular model 
A      B  
       





concepts upon which the tissue model is based. The decline in APD was 
nonlinear across the early SR – AF spectrum suggesting potential exists for early 
detection use. 
In Fig. 5B, mean maximum membrane potential change increased as 
predicted23, in the model, from 14 mV/ms to 22 mV/ms through the SR to AF 
spectrum and is consistent with the concepts upon which the tissue model is 
based. The non-linearity of the early change in upstroke velocity was more than 
that of the APD and of potential predictive use. 
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Fig. 6A and 6B are from literature describing the Markov model used to 
emulate the Ca SR release and Fig. 6C and 6D are outputs from the model. For 
clarification of SR notation the model outputs are calcium sarcoplasmic reticulum 
(SR) release, and the figure notation references SR - sarcoplasmic reticulum as 
well as the model state is sinus rhythm SR. The Markov Ca SR release gate 
A      B 
         
C      D  
     
Fig. 6 Ca SR release kinetics for the tissue model (A) Markov model for Ca 
release28, (B) Markov model variables28,86 , (C) Ca SR release Markov gates, 
(D) Ca SR release activity profile. The Ca release flux mirrors the Markov gate 
states in form and timing of peak. 




KI - RyR Ca-dependent inactivation rate 
KIM - RyR re-priming rate 
KO - RyR Ca-activation rate 
KOM - RyR deactivation rate 
O - Open State 
I – Inactivated State 
R – Resting State 




profiles (Fig. 6C) match literature28 with rapid opening, inactivation and then 
gradual transition to resting state. The model also produced the Ca SR release 
flux (Fig. 6D) as expected.   
In Fig. 7A, the calcium concentration measured in the fourth pulse in the 25th 
tissue strand decreased as predicted23, in the model from steady state of 2.5 mM 
to just under 1 mM and this matches literature8,12,14. In Fig. 7B, the peak calcium 
current was expressed 50 ms earlier and at 1.5 mV higher amplitude in the AF 
AP cycle than the SR AP cycle. Steady state calcium currents were similar 
between AF and SR with AF 0.1 mV below SR. This is attributed to the calcium 
buffers and is consistent with literature23,26. 
For the acetylcholine (ACh) challenge (Fig. 8A), code was constructed to 
simulate the IKACh challenge similar to the Grandi et al.23 model. APD23,83 
decreases with increasing ACh concentration as expected. 
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The AVE0118 challenge is shown in Fig. 8C and 8D. AVE0118 blocks the Ikur 
channels Kv1.5 and Kv1.382. Ikur channels are unique to the human atrial 
chambers assisting in providing the sharp drop in AP form necessary for rapid 
AP adaptation. AVE0118 does not adversely impact the human ventricles, thus 
providing a potential arrhythmia drug for AF with no detrimental ventricle side 
effects. As in the acetylcholine challenge, code was constructed for the AVE0118 
simulation of IKur block similar to the Grandi et al.23 model. Simulation of IKur 
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Fig. 8 Model validation for acetylcholine and AVE0118, (A) APD –
Acetylcholine Challenge, (B) Y State Variable in AVE0118 challenge, (C) AF 





block82 was initiated with a voltage gating factor inserted in the model and an 
initial condition of 0.01 for the state variable Y, in the PDEPE function, describing 
the changes in the fraction of unblocked IKur channels as in literature78. As per 
Fig. 8C and D, there was the expected change in AP form and duration in AF. 
The impact on Ikur was significant and notably greater at smaller concentrations of 
AVE0118 (Fig. 8D), suggesting, based on this model, that smaller dosages could 
be used to achieve the same impact on AF then described in literature. In 
addition to Ikur, AVE0118 is suggested79 to impact Ito and IKACh with IKur reduced 
more in AF than SR79.  
Whether inhibition of Ikur prolongs or shortens APD depends on the disease 
status of the atria and is determined by the level of remodeling81. Literature 
suggests the model should increase IKr and IKs - less in AF than SR; decrease 
APD in SR but increase it in AF and decrease the AP plateau phase of the AP 
wave form, which did occur, due to the impact of IKur. For the Y state variable in 
the AVE0118 challenge (Fig. 8B), the initial condition for state variable Y was set 
to 0.01 as a best estimate as no information was provided in literature. The Y 
variable tracked similar to the Grandi et al.23 model except for what appears to be 
potentially a difference in initial value, i.e. 0 for Grandi et al.23 model.  
For action potential duration by pulse variation (Fig. 9), the steady state12,80 
of the tissue model, was determined in a continuous run event of 32 pulses. The 
APD varied +/- 1.25% between pulses and is one indicator of model stability. The 
APD curves remained the same as the baseline used in the tissue model.  
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For computational purposes, previous studies have utilized a piecemeal 
approach, starting and appending the model where the previous run stopped (i.e. 
end of cycle). The study model was completed in a test scenario with the discrete 
appends of 64 pulses, and the model displayed similar results to continuous 
runs. For the study, all modeling runs were continuous events initiating and 
completing each scenario data set.   
The potassium currents, both with and without the Iks Markov model exhibit 
the magnitude reflected in the cell model, provided consistent timing reflective of 
the AP form as well as provide clear input on analysis of the gating factors 
involved. In summary the validation along with the baseline results are 
considered successful and provide support for use of the model in AF detection. 
 
3.2 Model Baseline – SR and AF 
The initial model baseline results were analyzed via membrane potential 
plots with for SR and AF conditions (Fig.10). The membrane potential plots were 
        





reviewed for continuity of form and consistency within the BCL parameter of the 
model run. As stated earlier, all model parameters remain the same except for 
the model atrial fibrillation factors parameters identified in Table 1, that 
differentiate SR from AF. The baseline is established by running 5 iterations of 
the human atrial tissue model with all parameters held constant except for the 
atrial fibrillation factor which is set to 0, 0.25, 0.5, 0.75, and 1 successively in 
each iteration to create 5 output sets. Fig. 11A shows the maximum membrane 
potential computed for every BCL and model iteration. Fig. 11B – 11F represents 
the discrete model iterations from SR through AF (graduated AF) on the 
horizontal axis, and the output for each iteration on the vertical axis. Each line 
chart in Fig. 11B-11F is a mean output measured across the tissue strand for 
each BCL, except for propagation velocity (Fig. 11D). As can be observed in Fig. 
11, 12, and 13 there is consistency in the directional movement of the model 
output measures, increasing or decreasing, as the model iterates across the SR 
to AF scale. Based on model validation and consistency of output, only the mean 
APD, mean propagation velocity, non-refractory time, mean AP upstroke velocity, 
and mean timing of maximum membrane potential change will be discussed. For 
model projects, input parameters were modified systematically as detailed in 
Tables 2 and 3 and compared to the baseline for each iteration (graduated AF) to 
determine if the variable was driving the model similar to AF conditions. The 
baseline SR and AF are shown in Table 6. For the model projects, if the change 
in the scenario propagation velocity is greater than 25% from the SR baseline, 
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Fig. 11 Model output variables for baseline comparison (A) maximum 
membrane potential by tissue state, (B) APD, (C) mean range of AP, (D) 
propagation velocity, (E) mean timing of maximum membrane potential, (F) 










Fig. 12 A and B represent mean maximum membrane change and mean 
minimum membrane potential which are consistent with expected AF behavior. 
Fig. 13 is mean timing in ms of minimum membrane potential and it is consistent 
with AF behavior expectations. Fig. 12 and 13 illustrate details of the increased 
peak AP potential and decreased minimum AP potential as AF developed in the 
model. 
A                B 
  
Fig. 12 Model output variables for baseline comparison, cont’d. (A) mean 
maximum membrane change, (B) mean minimum membrane potential. 
 




    Table 6. Propagation Outcomes (see footnotes below) 
 
SR - State - Baseline1 9.2 9.2 9.2 9.2 9.2
Graduated AF Factor 0 0.25 0.50 0.75 1
Senario Iteration 1 2 3 4 5
Modeling Senario
1 Graduated AF2 9.2 6.12 4.66 3.95 3.58
Cum Reduction 0 33% 49% 57% 61%
2 AF W/o_K+ adjustment3 9.2 8.93 8.43 7.68 6.94
Cum Reduction 0 3% 8% 17% 25%
3 AF W/o_Na+ and Ca2+ adj4 9.2 6.3 4.79 3.99 3.52
Cum Reduction 0 32% 48% 57% 62%
4 SR to AF Tissue Split5 9.2 6.11 6.24 5.96 -
Cum Reduction 0 34% 32% 35% -
5 SR to SR Tissue Split1,6 9.2 8.91 9.12 8.86 -
Cum Reduction 0 3% 1% 4% -
6 Cell Length Variation1,7 10.36 9.54 9.2 8.74 9.23
Cum Reduction -13% -4% 0% 5% 0%
7 Cell Radius Variation1,8 11.23 10.57 9.2 8.72 8.85
Cum Reduction -22% -15% 0% 5% 4%
8 External Diffusion1 9.2 8.78 8.1 7.58 7.53
Cum Reduction 0 5% 12% 18% 18%
9 Graduated AF Early 9.2 8.2 7.37 6.68 6.12
Cum Reduction 0 11% 20% 27% 33%
10 Junctional Volume Variation1 9.2 9.21 9.22 9.23 9.24
Cum Reduction 0 0% 0% 0% 0%
11 Intracellular Diffusion1 9.2 9.2 9.2 9.2 9.2
Cum Reduction 0 0 0 0 0
12 Iks Markov Implemented 9.17 6.1 4.66 3.95 3.58
Cum Reduction 0% 34% 49% 57% 61%
13 Acetylcholine Block1 9.2 9.08 4.17 2.36 2.36
Cum Reduction 0 1% 55% 74% 74%
14 AVE0118 AF Block 3.58 3.58 3.58 3.58 3.58
Cum Reduction 61% 61% 61% 61% 61%
15 AVE0118 SR Block1 9.17 9.19 9.2 9.2 9.2
Cum Reduction 0% 0% 0% 0% 0%
16 β Adrenergic Challenge1 9.2 6.9 5.17 4.04 3.35





3.3 Early AF 
The early AF element of the study compared the model output through the 
implementation of the AF parameters implemented in Table 2 from SR through 
the first two steps of code fibrillation factors in Table 3 to represent 25% of the 
AF adjustments. The cumulative impact of the first two steps of Table 3 are 
defined as early AF for this study. The results are illustrated in Fig. 14A through 
14E. The intent was to review the models ability to determine, based on the 
definition of early AF, 25% change in APD, wave propagation velocity and timing 
of maximum AP potential. The model potassium currents, model state variables, 
the INaK pump current, the Incx exchanger current, and ICLCFTR calcium dependent 
chloride current all contribute to the model nonlinear response to the mean timing 
of the maximum AP potential and propagation velocity. The calcium currents and 
concentrations as expected, showed no unusual activity in the early AF model 
run results. This provides a logical basis for the non-linear response observed in 
the first step (.25AF) of the model AF progression. In all parameters and in 
particular wave propagation velocity, the early AF model outputs followed the 
form of the full AF model run output and the final values matching the 25% AF 
value of the full AF model run. Wave propagation velocity in row 9, Table 6, and 
Table 6 Footnotes 
1 - All iterations run in SR state; 2 - baseline for AF detection comparisons created 
by implementation of Graduated AF Factors; 3 - K+ AF factors removed; 4 – Na+ and 
Ca2+ factors removed; 5 - AF factors implemented at tissue strip midpoint; 6 - 
scenario measured on iteration 4, iteration 5 illustrative only; 7 - midpoint of range 
variation is SR norm meaning the midpoint value is the SR norm for the model; 8 - 




the mean timing of the maximum AP potential were nonlinear in the model output 
during the first 25% of AF onset, reducing 3 of 5.6 um/ms and 90 of 160 ms 
during this period, a change greater than the 25% threshold, thereby providing a 
potential detection key in the effort to detect the early onset of AF. While the 
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other parameters were more linear in change, it does indicate that wave analysis 
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Fig. 14 Early AF detection modeling scenario outputs, (A) early AF APD, (B) 
early AF mean membrane potential change, (C) early AF mean non refractory 
Time %, (D) early AF propagation velocity, (E) early AF mean timing of 







based on full model AF output including mean timing of the maximum AP 
potential and wave propagation velocity, will be a potential but challenging, 
based on normal atrial variability, to detect early AF.   
3.4 Split Tissue Condition 
Cardiac tissue, including the atrium, displays inhomogeneity in structure and 
microstructures56 that are believed to contribute to AF14,31,36. The model was able 
to support split modes – specifically the concept of initiating the model in either 
SR or AF mode and then at a prescribed time or distance change to a different 
mode such as from SR to AF or a gradient of AF. Achieving the split tissue 
condition modeling involved splitting the mesh into separate sections via the 
PDEPE function with an “if  x > * value” statement and if true then updated model 
constants were inserted into the PDEPE workspace through the global 
“data.variable” for the duration of the pulse. The split tissue is additionally 
intended to represent the phase singularities believed needed to initiate rotors44. 
The split tissue model involved two modes of tissue splitting with two significantly 
Table 7. Split Tissue Variation Values 
 
SR - SR SR - AF
Iteration
1 0.0035 0.0035
2 0.0035 - 0.0007 0.0035 - 0.0007
3 0.0070 - 0.0035 0.0070 - 0.0035




Split Tissue Variation Table
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different outcomes; first, SR tissue was split with different diffusion coefficient 
values. The diffusion values were derived from analysis of the equations from the 
Model Mathematics section 2.4 and arbitrarily set to represent non-homogeneous 
tissue through distribution of gap junctions. The external diffusion coefficient was 
modified to model a decrease in gap junction resistance as compared to SR. The 
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underlying tissue remained SR state while, at cell 50, via the method described 
above the diffusion coefficient was changed per Table 7. Second, model 
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Fig. 15 Modeling of tissue inhomogeneity output results (A) split tissue APD , 
(B) split tissue mean maximum membrane potential change, (C) split tissue 
mean non refractory time %, (D) split tissue timing of maximum membrane 









iterations were done with the tissue state changing as well from SR to AF along 
with the change to the diffusion coefficient. In Fig. 15A through 15E, the curves 
are labelled with the diffusion coefficient values as “from - to” .The split tissue 
change in diffusion had relatively little impact, less than 25%, on the studied 
wave variables (also confirmed Table 6, row 5). In Fig. 17A, which is SR state, 
the impact of a 10X change in the diffusion coefficient can be seen on the 
membrane potential plot in agreement with the small change observed in the 
results discussed later in the section from standalone diffusion coefficient 
variation. However the “mean” output measures in Fig. 15A through E disguised 
the small impacts in diffusion coefficient change that the membrane potential 
plots show in Fig. 17A. In Fig. 15A through 15E and Fig. 17B, which is AF state, 
the additional change in tissue state from SR to AF brought wave form 
characteristics in line with AF including greater than 25% change in propagation 
 
Fig. 16 Split Tissue Maximum Membrane 
Potential by Pulse  
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Fig. 17 Split tissue modeling membrane potential plot outputs (A) SR tissue 
membrane potential plot with split diffusion coefficient .0070 to .0007, (B) split 







step function matched the graduated AF function for the base line modeling.   
For a single step the model showed a dramatic demarcation resulting from 
the step change. By natural extension of the differential in wave propagation 
across the step boundary, the split mode modeling allows presentation of the 
beginning of a potential AF wave front and discontinuous propagation14 modeling 
upon which additional analysis of wave front angle could be measured to 
correlate with rotor development14,31 .  
3.5 Isolated K+ and Na+, Ca2+ Ionic Impacts 
In Fig. 18A through 18E, the model was run with all variables and constants 
set to SR state and the AF initiating conditions split into the K+ and Na+, Ca2+ 
components. Literature28,34,50,64,65,66,68 suggests that channel pathologies can and 
do develop independent of each other and it could logically be concluded such 
happens in early AF. The non K+ component change meant that IKs, Ikur, Iki, and Ito 
remained unchanged; conversely the non Na-Ca change meant those K+ 
elements were the only changes. In Fig. 18A and 18C, the differing effects of 
sodium, calcium and potassium are observed in parameters such as APD where 
isolating the effects of each results in AF development curves with K+ impacting 
early and Na+ and Ca2+ impacting later with an additive effect compared to the 
baseline model. In Fig. 18B and 18D, the isolated effects have the appearance of 
K+ effects, with K+ mirroring and matching the baseline AF development curve 
suggesting singular K+ effects on developing AF. Na+ and Ca2+ effects are minor 
on propagation velocity and mean timing of maximum membrane potential 
change. As seen all potassium channels reflect faster K+ impacts (also discussed 
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later in Fig. 29). The significance of these models’ results are that if early AF 
conditions do in fact develop in isolated ionic channels, either in Na+ and Ca2+ or 
K+ channels, then wave analysis, electrocardiographic imaging, or other methods 
would potentially show results that may be indicative of potential developing AF 
conditions. A limitation of this analysis is that Grandi et al.23 did not provide these 
conditions as AF. The study is drawn from literature34, 50,55,58,64,68 and providing 
this scenario as a potential hypothesis for future modeling, has clinical limitations. 
All other model parameter outputs displayed similar results. It is a possibility that 
an unbalanced ionic condition such as those modeled in this scenario could be a 
driver of remodeling associated with early AF49,62 as well as be associated with 
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Fig. 18 Modeling variable outputs for the separation of Ionic effects (A) K+, Na-
Ca impact APD, (B) K+, Na-Ca impact mean maximum membrane potential 
change, (C) K+, Na-Ca impact mean non refractory time %, (D) K+, Na-Ca 










3.6 β Adrenergic Challenge 
Inherited gain-of-function mutations of genes coding for subunits of the heart 
slow potassium (IKs) channel can cause familial AF88. A potentially prevalent 
mechanism is that β-adrenergic receptor (β-AR)-mediated regulation of the IKs 
channel, a natural gain-of-function pathway, can also lead to AF. Computational 
modelling has revealed that β-AR stimulation-dependent accumulation of open 
IKs channels accounts for the pro-arrhythmic substrate. Evidence exists that β-
AR-regulated IKs channels can play a role in AF and imply that specific IKs 
deregulation, perhaps through disruption of the IKs macromolecular complex 
necessary for β-AR-mediated IKs channel regulation, may be a novel therapeutic 
strategy for treating this most common arrhythmia. 
Isoproterenol (ISO) simulation of β -Adrenergic challenge PKA-specific 
regulation of various targets was modeled as following23: IKs maximal 
conductance was enhanced (3 fold) and the current-voltage relationship was left-
shifted (by 40 mV); IKur maximal conductance was enhanced (3 fold)34; troponin I 
affinity for Ca2+ was decreased (i.e., kd was increased by 50%); Ca2+-sensitivity 
of SERCA was enhanced (i.e., the forward mode km was reduced by 50%); L-
type Ca2+ channels were increased (+50%) and channel availability was shifted 
leftward (by 3 mV); RyR sensitivity for luminal Ca2+ was increased (2 fold); affinity 
of Na+ pump for intracellular [Na+] was increased by 25%. The β-AR challenge 
was implemented in a structure in the same manner as the AF state, therefore 
allowing for a graduated implementation similar to Table 3. As in most of the 
previous scenarios the β-AR model iterations were conducted on the SR state of 
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the tissue model to isolate the effects of β-AR challenge. Fig. 19A and 19B, the 
show that propagation velocity and mean timing of the AP potential maximum 
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Fig. 19 β Adrenergic challenge results A) propagation velocity, B) non-
refractory period, C) maximum membrane potential change, D) mean APD, 
E) mean timing of maximum membrane potential change. 
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In Fig. 19B and 19D, the model non refractory period was more significant in 
the ISO than was the change in APD, suggesting the threshold for AF was less 
than the impact of the β-AR mediated regulation of IKs. Therefore, if the β-AR 
impact is correct, then the gain of function impact in IKs surpasses the AF 
threshold for impact, implying that during ISO challenge the β-AR is responsible 
for AF. Fig. 19C illustrates, in the β-AR challenge model output, the mean 
maximum membrane potential change matches in AF and ISO challenge. In row 
16, Table 6, the β-AR challenge scenario changes propagation velocity by 64% 
at AF end state and 25% in early AF than required. The conclusion drawn is that 
the model is generally more sensitive to AF as defined by Grandi et al.23 to detect 
AF as defined by the β-AR challenge and therefore the analysis is a potentially 
useful tool in early AF modeling.  
3.7 Potassium Ionic Flows and Markov Models 
In all scenario simulations the potassium currents responded as generally 
predicted in literature. The timing and content of the potassium response varied 
as described below. 
Ultra rapid activating potassium current Ikur,(down regulated 45% in AF) is 
shown in Fig. 20A. As indicated in the earlier AVE0118 model validation 
discussion the Ikur channels are unique to the atrial tissue and therefore offer 
potential unique detection and mediation opportunities. The Ikur responded to the 
Grandi et al.23 model AF adjustment as expected. Voltage activated gates, r – 
activation and s – inactivation, indicates that the membrane potential increase in 
AF increases the initial Ikur current through gate r, Fig. 20B to 20C, and s returns 
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to near normal state. The same membrane potential increase causes the 
inactivation gate s to initiate and remain at higher activity levels, Fig. 20D to 20E, 
therefore overriding the r activation impacts. The resulting Ikur current, Fig. 20A, is 
significantly increased in the early AP form and then depressed with the 
expected resulting higher and shorter AP form. The behavior of the Ikur channel 
gates in this model are contributors to the nonlinear behavior of the wave forms 
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Fig. 20 Ikur current analysis (A) Ikur current, (B) Ikur r activation gate in AF, (C) 
Ikur r activation gate in SR, (D) Ikur s inactivation gate in AF, (E) Ikur s 








Slowly activating potassium current IKs (up regulated 200% in AF) shown in 
Fig. 21A through 21C – shows that the IKs current responded to the model AF 
state with a significant nonlinear increase. The IKs is the principal repolarizing 
current. The sharp nonlinear increase in IKs current in Fig. 21A, caused by the 
upward shift of the activation gate x in Fig. 21B helps drive the shortened AP 
form and consequential shortened APD. The equilibrium value for IKs current is 
A       B 
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Fig. 21 IKs current analysis (A) slowly activating IKs current, (B) activation gate 
x in AF, (C) activation gate x in SR. 
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driven by the intra cellular concentrations of K+ and Na+ and consequently further 
impacted by the activity of the Incx pump in AF stimulation. The single activation 
gate of the IKs model is also both time and voltage driven with heavier 
dependence on voltage – i.e. voltage factor in the time constant calculation. The 
activation gate x is squared in the current calculation, driving the nonlinear 
response and also impacting rate adaption. The conductance is fixed in the 
model but offers another opportunity for expression modeling. The genetic 
linkage to AF is through the 4 α subunits KCNQ1 and 1 β subunit KCNE1. The 
KCMQ1 IKs α-subunit mutant is associated with familial AF, and the LQT and 
SQT syndromes53,54. The model results, the genetic linkage and known 
pathologies, offer potential for the early AF detection. In the Markov model, the 
IKs repolarization reserve can accommodate IKs impairment.  
The IKs Markov model for polarization reserve, as illustrated in Fig. 22A, 
functioned as expected when activated. The Markov transition factors β, η, δ, γ, 
ψ, α, and θ along with the definition of zone 1, zone 2, and open states were 
direct from literature23,27,34. The Markov gates, as shown in Fig. 22B functioned 
as expected in the human atrial tissue model and as characterized in 
literature11,27,34 with a rapid open state increase and then the zone 1 steady 
increase referred to as the repolarization reserve. As seen in Fig. 22C, the 
relative amplitude of the current, -.005 to +.035 µA mutes the effect on the 
membrane potential, however the absolute AP form and position are impacted by 
the models in these scenarios. The behavior IKs of is more accurately stated, 
earlier repolarization activity through the reserve, with the Markov 
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model11,26,27,28,34 and therefore more desirable. Note row 12 vs row 1, Table 6, 
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Fig. 22 Modeling results for Markov IKs are consistent with literature (A) IKs 
Markov Model34, (B) Markov gate profiles, (C) IKs currents w and W/o Markov 





Fig. 22D and 22E show very modest changes that are small noting the mean 
method of the value calculation for APD. Model constants within the Markov 
model match the predecessor ventricular model28 and were modified, such as IKs 
conductance, for atrial tissue through literature research.  
Time independent potassium current Iki (up regulated 100% in AF), shown in 
Fig. 23, indicates that the Iki current responded to the AF state with a sharp spike. 
Iki channels close upon depolarization, slowing membrane repolarization and 
helping maintain a more prolonged cardiac action potential – a key contributor to 
the lower membrane resting potential in the model AF state. In the tissue model, 
the Iki current moved forward approximately 200 ms in the action potential with 
peak outflow 2x as per the AF factor maximum 1.0. The forward movement 
helped shorted the APD.  Iki is an inward rectifier channel that, by mediating a 
small depolarizing K+ current at negative membrane potentials, helps establish 
resting membrane potential. The up regulated Iki as expected, throughout the 
propagation wave, drove the lower resting membrane potential in AF. As seen in 
Fig. 23B and 23C, the Iki channel has a single activation gate regulated by 
voltage driven activation and inactivation factors. In Fig. 23D, the activation gate 
moved forward and upward with the AF state. Genetic linkage to AF is through 
the KCNJ2 potassium subunit, a gain of function can cause the natural atrial 
pacemaker function to be suppresses through lower membrane resting potential 





Transient outward potassium current Ito (down regulated 45%in AF) and 
shown in Fig. 24A through 24C decreases as the AF factor increased. The 
results, as seen in Fig. 24A, illustrated the decrease in a nonlinear manner from 
SR to AF and a forward movement in the AP by approximately 100 ms. The 
down regulated Ito aided the higher AP profile and propagation wave form. In Fig. 
24B and 24C, Ito consists of fast activation and inactivation gates that are both 
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Fig. 23 Modeling outputs for Iki current are consistent with literature and drive 
AF (A) time indepedndent Iki, (B) activation gate factor aki, (C) inaction gate 
factor bki, (D) Iki activation gate SR and AF. 






time and voltage dependent. Both time constants have a squared factor that 
quickens the Ito activity in the model. Given the significant change in Ito current, 
the Ito gate profiles between SR and AF appear relatively stable. Ito conductance 
is used to introduce the down regulation of the channel while the  equilibrium 
value was fixed. The AF genetic linkage is through loss of expression of KCND2 
and KCND3 and is often driven by chronic α-adrenergic stimulation. Angiotensin 




Fig. 24 Model output for Ito current drives AF as predicted (A) transient 
outward Ito current, (B) Ito gate profile AF, (C) Ito gate profile SR. 
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II also reduces channel expression35. Both adrenergic and angiotensin II drive 
blood pressure as a potential indicator.  Linkage to AF allows for the shift to more 
inward Na+ as the fast Ito outward is muted. This causes an increase in the AP 
plateau and Ikp, which has the downstream effect of decreasing the electro-
chemical force of Ca2+ and ICa. This indirectly impacts the excitation-contraction 
relationship in a negative manner as well as drives wave disturbances creating 
and or facilitating other conditions for AF. Given the cascade effect of the Ito 
channel and association with blood pressure indications, future tissue modeling 
could focus more specifically to Ito and the opportunity for early detection of down 
regulation. 
Plateau potassium current Ikp – Ikp was not directly altered by the AF factor 
but did respond to the system (Fig. 25A through 25C) with an approximate 10x 
spike in equilibrium current and moved forward by 100 ms in the AP and 
propagation wave. This impact occurs because the Ikp current and activation gate 
are voltage driven and time independent, with the conductance and equilibrium 
values fixed. As in the IKs current, the Ikp current is small in magnitude but does 
impact the AP form. AF genetic linkage is generally assumed to be associated 
with the understanding that Ito sets the Ikp activity level – i.e the level at which the 
plateau is established. The “leveraged” effect, through voltage, of Ito on Ikp helps 
explain the large jump in Ikp even without an AF factor. Elevated Ikp drives 
positive membrane plateau current with potential impacts to drive higher IKs and 
consequently higher resting potentials which enable faster tissue excitation and 
the potential for re-entrant currents, rotors and other AF symptoms. In the 
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literature, genetic conditions related to Ikp are often discussed as insignificant 
contributor to AF development, however the tissue model demonstrates Ikp does 
participate in AF. 
 Rapidly activating potassium current IKr shown in Fig. 26A through 26C, was 
not impacted by the AF factor but did increase with the membrane potential 
impact as well as stayed in-place relative to timing as compared to the IKi 
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Fig. 25 Modeling output for Ikp current shows driving AF and impact to IKs (A) 
plateau Ikp, (B) Ikp activation gate AF current, (C) Ikp activation gate SR. 
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currents. IKr was calculated with a dual gate model, one within the PDEPE solver 
as a time and voltage dependent variable and the other as a time independent 
rectifier gate. The equilibrium value was fixed and the conductance value was 
driven by extra-cellular potassium concentration which was held fixed in the 




Fig. 26 Model output for IKr current shows impact of duel activation gates (A) 






model. IKr is assumed to be compensated for by IKs in the Markov models 
although it is still linked to AF. IKr is genetically linked to AF through its 4 identical 
subunits encoded by HERG. Mutations of α-subunits KCNE2 and KCNH2 are 
associated with Familial AF and the LQT and SQT syndromes and hence provide 
leverage for potential early detection. 
IKACh, – modeled in the acetylcholine challenge, is activated by muscarinic 
receptors and called a muscarinic potassium channel. These channels are a 
heterotetramer composed of two GIRK1 and two GIRK4 subunits. IKACh in the 
heart, when activated by parasympathetic signals through M2 muscarinic 
receptors, causes an outward current of potassium, which slows the heart rate. 
Inward rectifier channel activation of IKACh hyperpolarizes the membrane potential 
and abbreviates the action potential which was demonstrated in the validation 
scenario challenge. 
The model, in response to the AF factors, through a combination of Na+, 
Ca2+ and K+ actions increases membrane voltage and initiates a cascade of the 
K+ channel impacts that both heightens, through Ikur and Ito,  and deepens, 
through IKs and Ikp  the AP form while shorting the APD through IKs. The 
combination of these actions decreases wave propagation velocity and increases 
the area of non-refractory tissue. The summation of the nonlinear responses of 
the K+ channels provides the foundation for building potential early AF detection 
tools. This concludes the discussion of the potassium ionic channel behavior in 
the model and INa is now discussed because of it relevant impact.   
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Sodium current INa is shown in Fig. 27 and 28. The INa current was not 
directly altered by AF code, but did respond with a 2x increase in current, 
standing almost in place during the AP and wave propagation. This pump current 
would drive a corresponding higher sodium impact on the AP form and wave 
propagation velocity helping explaining the higher electrical heart wave form the 
model displays. This showed through in the Early AF Detection section as a 
driver of earlier non-linear voltage gate driven model response. With the 
exception of the addition of the late INaL component, Na+ was not a specific driver 
of the model response but, once the AF stimulate was initiated, Na+ facilitated the 
impacts in conjunction with the K+ channels. In Fig. 27C and 27D, the Na+ 
participation was accomplished primary through the slow inactivation gate j of the 
model. While the genetic and kinetics of Na+ are not the subject of this study, 
they do offer an opportunity for early detection and mediation of AF albeit the Na+ 
channels are not differentiated in the atrial chamber tissue to the same extent as 
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Fig. 27 Model output for Na+ current shows the impact of the Slow inactivation 
gate (A) INa  h fast inactivation AF, (B) INa  h fast inactivation SR, (C) INa  j slow 




3.8 State Variables and All Ionic Flows 
Fig. 29 illustrates the SR to AF state current comparisons and Appendix E 
illustrates the state variables in both SR and AF, and Appendix F lists the tissue 
model variables. The charts provides a summary graphic overview of the ionic 
flows in the model comparing the SR and AF states for 19 ionic 
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Fig. 28 INa current cont’d. (A) INa current SR – AF, (B) INa m activation AF, (C ) 



















 currents and for the 58 state variables in the model. 
In Fig. 30 for the ICaCl, Ca Flux and Incx exchanger currents, the Na+ and Ca2+ 
currents provide further definition of the AF AP wave form and associated 
propagation velocity. The Incx exchanger is driven by the sarcolemma and 
junctional sodium to calcium binding factors that are in turn driven by membrane 
potential and sodium and calcium intra compartmental concentrations. The 
binding kinetics terms are all defined with nonlinear terms such as factors raised 




Fig. 30 ICaCl, Ca flux and NaCa exchanger currents (A) ICaCl current SR – AF, 
(B) Ca flux flows, (C) Incx exchanger current.  
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to the 3 power which further drives the Incx response in the model. Late sodium 
channels, inactive in SR and active in AF, contribute to the model response of 
the Incx channels as well. The increased sodium then drives the response in Ca2+ 
channels. The ICaCl current, although small is driven by membrane potential and 
binding factors. Finally, the introduction of the AF factor in the Na+ and Ca2+ 
association, disassociation and binding factors contributes to the AF current 
profile exhibited in the AP form. 
3.9 Safety Factor 
As reported in other studies76,77 the Safety Factor calculation (Fig. 31), 
provided inconsistent results throughout the modeling process although generally 
in the relative range of values. The conditions the model was intended to create 
were not necessarily consistent with the conditions which the safety factor would 
provide the predicted otucomes14,74. In most safety factor analysis the conduction 
velocity slowed, which it increased in these simulations. Also, gap junctions 
increased and in these simulations gap junctions decreased. These are not 
contradictory outcomes as these difference limitations are discussed in literature 
with the application of the safety factor14, 64,65,74,76. Consequently, at times the 
 
Fig. 31 Safety of Propagation Factor14 
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calculation would present the AF wave propagation as more secure due to the 
higher peak action potential and the fixed basic cycle time. While the calculation 
appeared to be correct, the intended use as an early AF detection tool proved to 
be of limited value. As the modeling project developed and progressed the lack 
of correlation “physical” wave form led to the shelving of the concept for AF 
detection. In particular the project objective was to find detection methods prior to 
when the physical wave propagation would be physically impaired. However the 
methodology of calculating the Ionic currents provided a novel method to insert 
the safety factor calculations. In a future modeling effort based on a tissue 
correlated parameters the Boyle et al.76 model could be incorporated.  
The methodology of the modeling suggests, and the preliminary output of the 
model confirmed that the safety factor actually increased during the progression 
to AF as a result of the deeper and higher propagation wave form developed. 
Theory suggests that if the model could represent the actual wave break, that a 
decrease in the safety factor would occur as the wave disintegrated at the point 
of singularity.  
Results for external cell geometry, external diffusion, and internal cell 








Chapter 4 Discussion 
4.1 General 
The hypothesis was made that a human atrial tissue model could be 
developed to aid in the potential early detection and treatment of atrial fibrillation. 
The modeling demonstrates the potential to use signal analysis type 
characterization to identify patterns of the electrical heart wave that can be 
associated with the risk of developing human atrial fibrillation.  
The human atrial tissue model was responsive to the human SR inputs, as 
defined by Grandi et al.23 and demonstrated stability as Livshitz et al.12 described 
in utilization with a canine ventricular application. 
Overall the model provided a definitive response and characterization of 
atrial fibrillation in the human atrial heart. The sinus rhythm (SR) characterization 
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(Fig. 32A), in terms of  APD, refractory periods, propagation velocity, action 





Fig. 32 Membrane potential plot (A) tissue membrane potential plot – SR, (B) 





baseline against which other physical alterations of the human atrial cell could be 
compared. 
As compared to the SR state, the AF alteration of the cardiac ionic states and 
flows in the model, as defined by Grandi et al.23 provided a pattern of AF, Fig. 
32B, that includes quickened AP, reduced APD, reduced propagation velocity, as 
illustrated in Fig. 33A, and increased non-refractory tissue. The model output 
created by geometrical variations of the cells had much less response from the 
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Fig. 33 Model outputs (A) tissue propagation velocity, (B) comparative 
propagation velocity Outputs, (C) K+ currents SR, (D) AP view of 








SR state (Fig. 33B), in terms of APD, propagation velocity and other 
characteristics. The differentiation between ionic driven AF and the geometric 
manipulation of the human atrial cell was consistent throughout the 
characterization variables. Fig. 33D provides an AP flow in the same direction of 
the membrane plots and illustrates the shift of AP, APD and implied propagation 
in AF. The definition of human atrial fibrillation executed in the human atrial 
tissue model structure, suggests that early human AF detection via signal 
analysis is a distinct possibility as the model nonlinear response in early AF was 
distinctive. This observation is a particularly important in the model output for 
potential predictive uses. The tissue model responded as expected, in both SR 
and AF states, to known drug treatments, AVE0118 and acetylcholine, utilized in 
the treatment and study of AF. The AF characterization variables, shown as 
model outputs in Table 4, were consistent throughout the various stages of AF 
modeled and, if truly replicative of potential human conditions, could be used to 
predict potential AF development with the caveat that further correlation with 
human cardiac atrial tissue is required.  
The model provided definitive characterization of potassium currents in SR 
(Fig. 33C) and for the various stages of AF development. While the SR versus 
AF from Grandi et al.23 represents a seemingly straight forward adjustment to 
state variables the modeling indicated predicting actual ionic results can be 
difficult as buffers and other cellular elements responding to the inputs. 
Finally the modeling represents an extensive array of ionic current flow and 
state gate data, with 59 state variables, 18 unique ionic currents, as shown in 
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Appendix D, and advanced sodium and calcium buffers. With the excitation-
contraction coupling expressed through the Ca2+ ionic flows, fluxes, and 
concentration buffers, the Human Atrial Tissue model has, with appropriate 
correlation to human data, potential significant uses for other hypotheses 
concerning atrial fibrillation, its detection and its management. 
4.2 Wave Break 
Further analysis can be done by running the model on a 16 or 32 BCL split 
tissue iteration that can allow for calculation of the angle of wave break, as in Fig. 
35A and 35B31, to model tissue area versus the opportunity for rotor 
development. Fig. 34 provides more illustration of the developing break angle. 
The break angle is believed to eventually degrade along with the AP form and 
 




extended non-refractory periods into forms of AF in the tissue. Fig. 35A can be 
overlaid on Fig. 34 to illustrate the potential wave break developing in the model.  
 As discussed below in external diffusion impacts, different numerical 
methods identified in this study but not included in the report, could be used to 
model both distance and time step functions based on the AF inputs used in this 
study. 
Finally the PDEPE solver was challenged to calculate a 3 mode model such 
as SR to AF to SR which would provide an additional situation potentially 
representative of early cardiac remodeling. The numeric methods embedded in 
the PDEPE solver, for this study, could not estimate the additional step change 
and therefore the multiple step modeling was stopped. Future model code could 
be developed to potentially provide this functionality.  
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Fig. 35 Tissue inhomogeneity rotor development (A) wave break angle, (B) 





Additionally, the model illustrated the ability to represent transition zones, 
representing those areas where the human tissue transitions from SR to AF 
conducive properties. In Fig. 34 the propagation wave can also be distinctively 
characterized at those boundaries with the same wave properties. The output 
differential in the transition zones can be correlated to the mathematical 
properties of the wave breaks and rotors to potentially create more advanced 
modeling scenarios that represent the human experience phenomenon. 
4.3 Rolling Pulse 
One additional item noted for further attention in future studies is the 
phenomenon of pulses rolling over BCL time frames, in Fig. 36, which shows a 
cross BCL membrane potential plot, as an example of further potential 
opportunities identified in this study. The analytics extract could have been 
designed around dynamic pulse selection although the results interpretation 
would be more complex. However the method of taking the last t values across 
all x in the model solution allows the model to run indefinitely assuming the 
human tissue correlation is done and the model stability persists. Output run in 
this manner suggested that with split tissue scenarios and further extended 
distance, such as 400 cells, the model may show characteristics of discontinuous 
propagation similar to emulating initiation of AF.      
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 4.4 Novelty 
The project is unique and innovative in that it transforms a known validated 
cell model developed by Grandi et al.23 into a tissue model that can be 
used/leveraged to help develop potential early detection methods for AF to delay 
or prevent AF associated cardiac remodeling. This model incorporates some of 
the most advanced cardiac cell structures in a packaging that offers reasonably 
quick iteration time and can be modified for use regardless of the physiology of 
the particular form of AF. To date there are few models focused, based on the 
complex and complete cardiac cellular structure, on establishing a starting point 
for AF analysis in tissue.    
  
 
Fig. 36 Extended tissue membrane potential plot – model extended by taking 
8 pulse continuous event runs and “appending” via final time slice as initial 
conditions t0 for next run. 
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4.5 Next Steps  
The next steps would be to calibrate the model with actual human atrial data 
to validate all outputs of the model. This step would provide a level of accuracy in 
the model that would enable meaningful studies long duration, 1-5 minutes, 
analysis of larger tissue strips, up to 1 X 10 cm is size. The utilization of 
advancements in Langendorff phenotyping85 to further refine existing and 
additional cell kinetics could further support the early AF analysis with both better 
cell definition and identification schemes based on the preponderance for AF on 
genetic basis. 
Further, leveraging analytical outputs of optical mapping, Langendorff 
ejecting heart preparations32,85, and electrocardiographic imaging with the model 
ion channel kinetics could enable a more advanced model elements to predict 
electrical wave patterns of arrhythmias. Correlation with electrocardiographic 
imaging tools can also potentially provide predictive analysis capabilities to the 
model. 
Leveraging electrocardiographic imaging tools to improve the tissue 
modeling would potentially enable focus on analyzing the characteristics of early 
heart development as well as modeling the initial characteristics of the 
development stage of AF in the young human heart. The advantage of the tissue 
model detail is that its flexibility is still maintained albeit with significant 
complexity. The flexibility of the complex tissue model can enable simultaneous 
modeling of multiple stages of the young human atrial development in a manner 
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which can be useful in determining the potential sequence by which humans 
develop AF event at the ion channel level.    
Beyond enhanced kinetics and cell definition, incorporation of ephaptic 
concepts84 in the model would be a significant step in potential understanding of 
how the heart wave propagates and mysteriously reappears within non-refractory 
or near non-refractory tissue structures. The incorporation of equations that can 
model potential ephaptic effects84 of cell to cell conduction in particular in relation 
to the tissue refractory opportunities would be a significant step towards a 3D 
model more suited for Finite Element and bidomain modeling tools but still at a 
much more advanced cell kinetics definition. Understanding ephaptic effects 
through tissue modeling also offers insight into the application of current 
pacemaker technology applications in order to reduce the adverse effects and 
improve their efficacy.   
At the modeling level, development of geometric relationships in the cell 
models relative to channel proximity and cell size can potentially enable analysis 
and tissue modeling of the role of ischemia proximity tissue in AF and adverse 
development characteristics. The current model lacked this functionality but it 
can, with modest detail incorporate such functionality to the extent that actual 
human atrial data could be used to calibrate the state variables.  
Further development of AF definitions for use as predictors to be modeled as 
potential clinical screening applications are a vital next step in the early detection 
of developing AF. The current model made use of a scheme that, while relevant 
for the study, needs clinical verification to have clinical validation. This model 
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also used a scheme for classifying early AF, 25% of the AF adjustments, that 
also needs clinical foundations. The model assumed a logical progression of AF 
but can easily adapt to non-linear and less straightforward approaches to the 
early stages of development of AF analysis where efforts can be directed. 
 Additionally, given the suggestions of further enhancements and flexibility of 
the tissue model as run for this study, it would only be logical to explore the 
application of the cell model to 3D models such as Finite Element tools and or 
the Bidomain models. Models built on parallel processing platforms or on 
software leveraging the advances in electronic computing hardware, native 64 bit 
application code and advanced MATLAB code offer opportunities for the fast turn 
scenario analysis on a more advanced model upon which the 
electrocardiographic imaging could be correlated with. 
Finally, the human atrial tool as developed can be integrated as a tissue 
model, where current cellular models are used21,29,30,31, for integrated AF analysis 
with 3D tools, rotor and wave analysis and electrocardiographic imaging to 
further the understanding and predictive abilities in AF.   
4.6 Model limitations  
The human atrial tissue model proved to be stable and provided consistent 
results primarily from the standpoint of arrhythmia development23,26,28. The model 
does have limitations that in some cases can be addressed and in other cases 
are inherent to Silico modeling. Addressable limitations include complexity, the 
model is 60 state variables, 19 ionic currents (more in the AVE0118 and 
acetylcholine challenges), and 4 layers of coding. The model is very appropriate 
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for the AF analysis challenge but the results require a level of verification well 
beyond most of the cardiac models in literature. The model was not run on a 
parallel processor platform but can be – the run time, even on advanced desktop 
devices is over 3 hours and significantly greater for extended versions of the 
model. With such run times specific modeling becomes tedious and error prone. 
The MATLAB code is much improved in the R2014a versions relative to resource 
management and function call for PDEPE but still lacks an informative user 
interface for the activities of the numeric solver hence the range of values from 
10e+3 to 10e-7 in the calculations can create potential errors or nuances. The 
tissue model initial conditions are from a cellular model by Grandi et al.23 and 
extrapolated linearly for a tissue model, which while not necessarily incorrect, 
suggests an improvement by using physiological data from a two or three 
dimensional set up and output. The model needs human left atrial data to 
validate the kinetic equations, confirm the constants values and verify the model 
output. The model propagation velocity is slow for human atrial tissue which 
implies a fixed BCL may not be an optimal setup. The diffusion equation structure 
of the model is one of the most promising concepts but limited by the lack of 
correlation to human data. The model output suggests limited correlation 
between diffusion and AF characteristics however in real human atrial conditions 
the diffusion factor can be expected to be correlated with initial conditions of 
several state variables and model constants such as cellular concentrations. 
Finally, from an In Silico perspective, the model mathematics by definition are not 
independent functions such as in real human atrial conditions and therefore will 
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not necessarily represent the spontaneous outputs experienced in real human 
atrial tissue. The cause and effect conclusions from the results must be always 




Chapter 5 Conclusions 
The Tissue model study resulted in 10 findings: 1) the model can represent 
both SR and AF conditions with corresponding wave form propagation, 2) the 
model can be validated against several other studies, 3) early AF, defined as the 
period between 0% AF factor and 25% AF factors applied, expresses the same 
characteristics but with much greater challenges in external wave form analysis 
of the rate of change, 4) external cell geometric changes on SR state tissue have 
much less significant impact on the model relative to analyzing AF conditions, 5) 
the model is able to represent split tissue conditions, primarily from SR to AF 
conditions and therefore potentially represent “at risk” boundary conditions 
capable of creating rotor conditions, 6) external diffusion coefficient changes, 
representing gap junctions, on SR state tissue have smaller but important 
directional impact on the model relative to displaying  AF conditions 7) possibly 
due to the calcium and sodium buffering/complexity, internal cellular geometric 
changes on SR state tissue have much smaller impact on the model relative to 
displaying AF conditions, 8) likely conditions for membrane potential driven 
channel remodeling can be modeled and analyzed, 9)  the model displays 
consistent but moving ionic states and conditions throughout the progression 
from SR to AF tissue state, and 10) isolated ionic conditions can provide analysis 
opportunities for specific wave patterns.  The elements used to analyze AF 
condition include left atrial14,17,29,46,47, epicardial86 heart tissue, ion channel 
specificity and expression35, comprehensive excitation contraction calcium and 
sodium kinetics, and time distance modeling. The modeling was validated based 
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on a complex but realistic cell model calibrated to human left atrial tissue. The 
model demonstrated stability over time in wave form and ionic kinetics, provided 
wave form output that not only aligned with expectations from literature, but also 
provided a rich basis upon which atrial fibrillation based wave analysis could be 
accomplished. 
The model suggests AF, through ionic kinetics, can be represented by a 
heightened AP, shorted APD, decreased wave propagation and increased non 
refractory tissue area. Further the tissue model does not contradict the concept 
that gap junctions are a significant contributing factor to AF. It is theorized the 
model construct did not account for the association/disassociation kinetic 
functions that would logically tie the diffusion coefficient, the mathematical 
representation, of the gap junctions to the geometry and diffusion coefficient 
change variation modeling hence a key correlating result were not seen. 
However there was model movement in the expected direction with pure diffusion 
coefficient variation. 
Human and experimental studies have shown that effective shortening of the 
AP refractory period, the period when the cardiac tissue cannot be depolarized, 
is an essential feature of atrial fibrillation17. The human atrial tissue model, as 
discussed, replicates that phenomenon as a logical extension of the wave form 
change – AP height and depth, and wave propagation changes and also reflects 
channel pathologies. The model provided ionic channel detail to potential genetic 
linkage though activation and inactivation factors. 
90  
 
AF has been characterized as having focal triggers in the pulmonary vein 
interface within the heart and left atrium36. The triggers manifest themselves as 
early after depolarization (EAD) and delayed after depolarization (DAD) with 
associated electrical waves. The tissue model demonstrated the potential to 
represent tissue environments required to facilitate EAD and DAD though 
increased wave height and non-refractory area growth. Maintenance of AF is 
through wave breaks and associated points of singularity (PS) in heterogeneous 
tissue.  The tissue model was able to replicate, via the split tissue scenario, how 
wave breaks and points of singularity could be generated which in turn would 
create the environment for rotors. The model provides a logical basis upon which 
a 3D model could be built in an effort to show reentrant points as a result of the 
wave breaks. Finally, the model provides a realistic human atrial tissue in Silico 
representation, albeit with complex structure, and has potential for use in related 
studies. The significance of a tablet or desktop model is the element of low cost, 
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Appendix A. Model Progression 
 
 
Atrial Vs Ventricular cAF  Vs Base Atrial Lone Atrial Fibrillation
Ionic Currents
Ina Unchanged -10% peak density Unchanged from base ventricular 
InaL Not in model Added Late Component Unchanged from base ventricular 
IKs Unchanged Increased 2-fold Gain of function from base atrial
IKr Unchanged Unchanged Loss of Function from base atrial
IKur Added -55% in the RA Loss of Function from Base atrial
-45% in the LA
Iki (IK1) 85% Reduction Upregulated +100% Loss of Function
Ito No Itos Itof Gain of Function
Itof
-80% in the RA
-45% in the LA
Activation and inactivation negatively 
shifftede and slower inactivation; 
larger amplitude
Ca and Na Handling
ICaL
Matched amplitude and 
kinetics at 37 deg 
Current density is reduced by 
50% in cAF. No Chnages in 
voltage dependence of 
activation and inactivation Unchanged from base ventricular 
Incx Atrium < ventricle (-30%) Upregulated in cAF (+40%) Unchanged from base ventricular 
Kd,act increased by 50%
SERCA No chnges in mximal oump rate Reduced maximal pump rate Unchanged from base ventricular 
Kmf increased 2-fold
RyR unchanged
Increased sensitivey for 
luminal Ca2+ (2 fold) Unchanged from base ventricular 
SR Ca2+ leak unchanged Increased by 25% Unchanged from base ventricular 
Tnl unchanged Unchanged Unchanged from base ventricular 
INak Atrium < ventricle (-30%) Unchanged Unchanged from base ventricular 
Model Progression 23 
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Type Gene Protein Functional Alteration
LQTS
LQT1 KCNQ1 I Ks  potassium channel α-subunit Loss of function
LQT2 KCNH2 I Kr  potassium channel α-subunit Loss of function
LQT3 SCN5A I Na  cardiac sodium channel α-subunit Gain of function
LQT4 ANK2 Ankyrin-B Loss of function
LQT5 KCNE1 I Ks  potassium channel β-subunit Loss of function
LQT6 KCNE2 I Kr  potassium channel β-subunit Loss of function
LQT7 KCNJ2 Iki (I K1 )  potassium channel subunit Loss of function
LQT8 CACNA1C Calcium channel α-subunit Gain of function
Short QT syndrome
S4T1 KCNH2 I Kr  potassium channel α-subunit Gain of function
S4T2 KCNQ1 I Ks  potassium channel α-subunit Gain of function
S4T3 KCNJ2 Iki (I K1 )  potassium channel subunit Gain of function
Brugada syndrome
BrS1 SCN5A I Na  sodium channel α-subunit Loss of function
BrS2 GPD1L G-3PD 1- Altered function
BrS3 CACNA1C I Ca  calcium channel α-subunit Loss of function
BrS4 CACNB2b I Ca  calcium channel β-subunit Loss of function
BrS other ANKRYN-B Ankryin-B Altered function
Catecholaminergic polymorphic VT
RYR2 Cardiac ryanodine receptor Gain of function
CASQ2 Calsequestrin Gain of function
Idiopathic sick sinus syndrome
HCN4 I f  pacemaker channel subunit Loss of function
SCN5A I Na  cardiac sodium channel α-subunit Loss of function
Cardiac conduction disease
SCN5A I Na  cardiac sodium channel α-subunit Loss of function
Familial atrial fibrillation
KCNQ1 I Ks  potassium channel α-subunit Gain of function
KCNE2 I Kr  potassium channel β-subunit Gain of function
KCNJ2 Iki (I K1 )  potassium channel subunit Gain of function
KCNH2 I Kr  potassium channel α-subunit Gain of function
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INa Inward Sodium Current (Fast Na
+
 current)
INAL Inward slow Sodium Current (slow Na
+
 current)








Ikr Rapid delayed rectifier K
+
 current
Iks Slow delayed rectifier K
+
 current
Ito Transient outward K
+
 current
Ito1 4AP-sensitive transient outward K
+
 current
Itr Ca2+ transfer from NSR to JSR, mmo;/L per ms
IK1 = IKi Time-independent K
+
 cuurent 
Ikur Ultr rapid delayed rectifier K
+
 current




















CaMKII Calcium/Calmodulin-dependent Protein Kinase II
PLB Phospholamban
JSR Junctional sarcoplasmic reticulum
NSR Network sarcolplasmic reticulum
CSQN luminal buffer calsequestrin
RyR Ryanodine receptor











Note current grammatical syntax is based on MATLAB code. 
 
Current Description
I_Na I_Na_junc I_Na_sl Fast Na
I_NaL I_NaL_junc I_NaL_sl Late I_Na
I_nabk I_nabk_junc I_nabk_sl Na Background Current
I_nak I_nak_junc I_nak_sl; Na/K Pump Current
I_kr Rapidly Activating K Current
I_ks I_ks_junc I_ks_sl Slowly Activating K Current
I_kp I_kp_junc I_kp_sl Plateau K current
I_to Transient Outward K Current (slow and fast components)
I_kur Ultra rapid delayed rectifier Outward K Current
I_ki Time-Independent K Current
I_ClCa Ca-activated Cl Current
I_Clbk background Cl Current
I_Ca I_Ca_junc I_Ca_sl L-type Calcium Current
I_CaK K/Ca Pump
I_CaNa I_CaNa_junc I_CaNa_sl Na/Ca Pump
I_ncx I_ncx_junc I_ncx_sl Na/Ca Exchanger flux
I_pca I_pca_junc I_pca_sl  Sarcolemmal Ca Pump Current
I_cabk I_cabk_junc I_cabk_sl Ca Background Current
SR fluxes
J_SRCarel Sacroplasmic Reticulim Calcium Release
J_serca Sacroplasmic Reticulim Ca pump
J_SRleak Sacroplasmic Reticulim Ca leak
J_CaB_cytosol Cytosolic Ca Buffer
J_CaB_junction Junctional Ca Buffers











































Name Variable Description UOM
Y1 mo sodium activation gate
Y2 ho sodium fast inactivation gate
Y3 jo sodium slow inactivation gate
Y4 do Calcium d activation gate
Y5 fo Calcium f activation gate
Y6 fcaBslo calcium junction inactivation
Y7 fcaBslo calcium sarcolemmal inactivation
Y8 xtoso to slow activation rate - not used
Y9 ytoso to slow  inactivation rate - not used
Y10 xtofo to fast activation rate
Y11 ytofo to fast inactivation rate
Y12 xkro kr open channels
Y13 xkso ks open channels
Y14 RyRro RyR inactivation rate
Y15 RyRoo RYR open state
Y16 RyRio RYR closed state
Y17 NaBjo Sodium concetration junctional buffering mM
Y18 NaBslo Sodium concetration sarcolemmal buffering mM
Y19 TnCLo Ca concetration in tropin C low state mM
Y20 TnCHco Ca concetration in tropin C high state mM
Y21 TnCHmo Mg concetration in tropin C high state mM
Y22 CaMo Ca concetration in Calmodulin mM
Y23 Myoco Ca concetration in Myosin mM
Y24 Myomo Mg concetration in Myosin mM
Y25 SRBo Ca concetration in sarcoplasmic reticulum mM
Y26 SLLjo Ca concetration in junction low state mM
Y27 SLLslo Ca concetration in sarcolemma low state mM
Y28 SLHjo Ca concetration in junction high state mM
Y29 SLHslo Ca concetration in sarcolemma high state mM
Y30 Csqnbo Calsequestrin buffer concentration mM
Y31 Ca_sro Ca concetration in sarcoplasmic reticulum mM
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Name Variable Description UOM
Y32 Najo Sarcolemmal sodium concentration mM
Y33 Naslo Junctional sodium concentration mM
Y34 Naio intracellular sodium concentration mM
Y35 Kio Junctional calcium concentration mM
Y36 Cajo Ca concetration in junction mM
Y37 Caslo Ca concetration in sarcolemma mM
Y38  Caio intra cellular calcium concentration mM
Y39 Vmo Membrane voltage mV
Y40  rtoso reserve to slow concentration - not used mM
Y41 AVE voltage dependent Ikur blocked gate
Y42 C1o C1o channel with 4 closed units
Y43 C2o C2o channel with 3 closed and 1 intermediate units
Y44 C3o C3o channel with 2 closed and 2 intermediate units
Y45 C4o C4o channel with 1 closed and 3 intermediate units
Y46 C5o C5o channel with 4 intermediate units
Y47 C6o C6o channel with 3 closed and 1 activated units
Y48 C7o C7o channel with 2 closed, 1 intermediate and 1 active units
Y49 C8o C8o channel with 1 closed, 2 intermediate and 1 activated units
Y50 C9o C9o channel with 3 intermediate and 1 activated units
Y51 C10o C10o channel with 2 closed and 2 activated units
Y52 C11o C11o channel with 1 closed, 1 intermediate and 2 activated units
Y53 C12o C12o channel with 2 intermediate and 2 activated units
Y54 C13o C13o channel with 1 closed and 3 activated units
Y55 C14o C14o channel with 1 intermediate and 3 activated units
Y56 C15o C15o channel with 4 activated units
Y57  O1o  O1o channel open early
Y58 rkuro kur activation rate
Y59 skuro kur inactivation rate
Y60 ml late sodium activation gate
Y61 hl late sodium inactivation gate
Y62 nalo late sodium concentration mM
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Appendix G. External Cell Geometry   
The model is held at SR as a baseline to see if the geometric changes 
“mimic” AF. With the model tissue state at SR the cell length was varied from 75 
to 200 µm and the radius from 8.25 to 13.325 µm with little if any impact on the 
SR state of the tissue and less than 25% change in propagation velocity as seen 
in Fig. 37A through 37D and rows 6 and 7, in Table 6. Since the model showed 
stability and the output variables all displayed the same characteristics, only 
A      B 
     
C D  
          
Fig. 37 Geometric variation of cell size modeling outputs (A) geometric 
variation APD, (B) geometric variation mean maximum potential change, (C) 
geometric variation propagation velocity, (D) geometric variation cell 
diagram28 Modified. SR value for length on green line = 100 µm. SR value for 







three output variables, APD, Mean Maximum Membrane Potential Velocity and 
Propagation Velocity are shown. Reducing the cell radius and length marginally 
increased the propagation velocity while the expanding the radius and length had 
insignificant change impact on the tissue SR state. From these observations and 
settings, the conclusion is drawn that at a macro level cellular geometry alone, 
within the tissue structure is not a driver or detectable measure of AF with this 
particular model. This is substantiated by the review of state variables from SR to 
AF in Appendix E as the external geometries provided only indirect input to 
channels states. The external geometries can influence buffer states and 
capacities through resulting impacts on internal cellular diffusion, channel 
densities and resulting ionic ratios if the functional relationships are known and 
modeled. One of the key features of the model is the adaptive calcium and 
sodium buffers which potentially mask changes driven by geometric factors. 
Further research85 in the study addresses the impacts of internal cellular 
variations in the cytosolic, junctional and sarcolemma geometries and diffusion 
characteristics as model study elements with similar results. While cell length and 
radius are contained in several Ca2+ and Na+ equations, there is no direct 
functional tie to channels per volume connecting external dimensions to internal 
cellular states. 
A review of Fig. 37C, with the green line (graduated AF) SR states for each 
variable conveniently aligned at the same AF step, does suggest that reducing 
the geometries may lead to lengthened APD, a directional shift opposite of this 
study but potentially of further study value. 
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Appendix H. External Diffusion Coefficient  
In Fig. 38A through 38D, comparison of the baseline SR to AF model to 
changes in diffusion coefficient and internal cell stimulation per the Livshitz et 
al.12 model was thought to recognize the impact of the diffusion coefficient on 
representing the physical impact of gap junctions on AF. The diffusion factor was 
set to increase, in comparison to the decrease in the split tissue scenario, to 
represent another potential form of cardiac pathology related to AF14. The 
A      B 
   
C         
    
Fig. 38 Modeling variable outputs for diffusion factor changes (A) external 
diffusion propagation velocity, (B) external diffusion APD, (C) external 






diffusion factor for this model was independent of the flux and ionic current 
adjustments in the cell component of the human atrial tissue model. In row 8, 
Table 6, propagation velocity change, while directionally aligned at 18% 
reduction was less than 25%. Reference the comments in external geometry 
analysis, the atrial tissue model is stable and the model outputs were consistent 
therefore only APD, wave propagation velocity and AP velocity are shown. The 
change in propagation velocity was theorized to be attributed to the impact of the 
increased axial current on the model structure of the Incx and INa channels which 
respond to the membrane voltage change driving the AP form, similar to the Na+ 
and Ca+ only changes discussed earlier.   
The diffusion factor, theoretically measuring the availability and or impact of 
gap junctions on the propagation velocity and electrical wave characteristics, was 
varied between a value of .0035 to .0275, i.e. a magnitude of 10, and showed 
impact on the SR state of the tissue through downward trending propagation 
velocity. The diffusion factor was increased in this scenario to represent current 
moving between cells with less control (gap junction structure) which is opposite 
from the direction in the split tissue scenario. It is worthy to note the diffusion 
factor, at a value above .0350 caused propagation failure. This is taken as 
confirmation the diffusion factor is driving model albeit not as intended without 
functional relationships between the coefficient and the internal cell workings. 
Comparison to the Livshitz et al.12 model supplemental information is not clear as 




As discussed earlier, for the diffusion coefficient impact, there are multiple 
factors not taken into consideration in this model – location of channels, a 
functional relationship between diffusion and half saturation constants that would 
make the cellular geometry and diffusion coefficient nontrivial factors in the AF 
output metrics. Additionally, the modeling by design, was intended to maintain 
stability through the various calcium and sodium buffers. The Livshitz et al.12 
model did offer a path to a more integrated diffusion function through the 
formulation 𝜆2 = (
𝑟𝑚
𝑟𝑖+𝑟𝑜






)/𝑐m which in a future study could 
correlate an intra-cellular conductance function with the relevant 
associations/disassociation constants within human cellular conditions as well as 
the relationship between geometry and diffusion. 




Appendix I. Internal Cell Conditions  
As in the discussion on external cellular geometry and diffusion coefficient 
changes, the speed of internal junctional ion diffusion and size of the junctional 
area relative to total cell size did not drive model output of discernable difference 
from SR conditions as illustrated in Fig. 39A through 39D. The junctional volume 
and sarcolemma to junctional and cytosol diffusion changes where intended to 
represent an internal cell modification representative of a potential form of early 
A      B 
   
C      D  
    
Fig. 39 Intra cellular geometry modeling results (A) intra cellular geometry 
APD, (B) intra cellular mean maximum membrane potential change, (C) intra 







remodeling. In rows 10 and 11, Table 6, neither scenario change propagation 
velocity by 25% and in fact were 0. Because the atrial tissue model was stable 
and outputs consistent, only the APD, wave propagation velocity and AP velocity 
are shown. As in the other nonionic impact analysis discussions the lack of 
functional connection between the conditions modeled and the internal cell 
structure and the design of the model through calcium and sodium buffers likely 
precluded and impact on the output parameters driven by AF. State variables, 
ionic currents and model outputs remained nearly constant throughout the model 
iterations over the range of geometrical values. The consolidated review of 
literature did not, from a practical point of view, discuss heart tissue conditions 
such as those modeled in this manner since if they existed at birth with AF 
associated ionic factors, they would probably be detectable immediately. 
However the possibility exists that these physical conditions, if existing, could 
facilitate remodeling of normal ionic channels into AF associated conditions. That 





Appendix J. Sample Summary Scenario Data Sets 
 
SR to AF Scenario Model Data Set           
       
 
Scenario Output Variable Comparison to AF 
 
 
Variable Scenario Model Data Set   
     
 






1 2 3 4 5
Input Change Variable SR .25AF .50AF .75AF AF
Refractory 0.571714 0.578078 0.589785 0.6179 0.66781
APD 513.9438 506.3063 492.2575 458.52 398.6275
MaxTMP 324.97 329.9225 324.5025 313.7313 299.0338
MinTMP 288.0463 293.5263 293.4213 289.6113 288.3775
MaxDeltaTMP 309.0438 314.8638 313.7575 304.1725 290.415
RangeTMP 85.73743 83.68445 81.9602 80.96917 80.42415
Maximum 10.79565 8.710775 6.927469 5.859629 5.251713
Minimum -74.9678 -74.992 -75.0456 -75.1186 -75.1795
ChangeTMP 14.64519 14.2773 14.00437 14.02187 14.05201
Prop Velocity 9.2 8.93 8.43 7.68 6.94
MATLAB ARRAY DATA
Model Iteration
Input Change Variable SR .25AF .50AF .75AF AF
Baseline Prop Velocity 9.2 67.12 4.66 3.95 3.58
Senario Prop Velocity 9.2 8.93 8.43 7.68 6.94
Chart Data
Report Out Against Baseline
Model State SR 1 2 3 4 5
Input Change Variable 75 90 100 150 200
Refractory 0.573156 0.572864 0.571713 0.560797 0.545119
APD 512.2125 512.5638 513.945 527.0438 545.8575
MaxTMP 346.6288 330.615 324.97 326.5625 356.1988
MinTMP 307.4125 293.1413 288.0463 289.6313 315.7713
MaxDeltaTMP 329.5275 314.3863 309.035 310.6513 337.765
RangeTMP 85.39157 85.6561 85.73741 85.67706 85.02473
Maximum 10.62383 10.76883 10.79562 10.66131 10.12945
Minimum -74.7965 -74.9148 -74.9678 -75.0346 -74.9099
ChangeTMP 14.39863 14.45057 14.64521 14.5471 13.93712
Prop Velocity 10.36 9.54 9.2 8.74 9.23
MATLAB ARRAY DATA
Model Iteration
SR .25AF .50AF .75AF AF
Baseline Prop Velocity 9.2 67.12 4.66 3.95 3.58
Input Change Variable 75 90 100 150 200
Senario Prop Velocity 9.2 7.47 5.74 4.57 3.88
Chart Data
Report Out Against Baseline
